Condition: Meningitis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Parenteral antibiotics
- Intravenous fluids
- Parenteral corticosteroids
|
|
< 5 years
|
|
|
- Parenteral antibiotics
- Parenteral corticosteroids
|
|
5 - 11 years
|
|
|
- Parenteral antibiotics
- Parenteral corticosteroids
|
|
12 - 24 years
|
|
|
- Parenteral antibiotics
- Parenteral corticosteroids
|
|
25 - 59 years
|
|
|
History and physical examination for meningitis
Clinical assessment for early recognition of the need for referral
Basic laboratory tests
Lumbar puncture
Systemic antibiotics for bacterial meningitis
|
|
60+ years
|
|
|
- Clinical examination
- Physical examination
- Supportive treatment for elderly persons with meningitis including:
- Fluids/IV fluids therapy for elderly persons
- Relieve fever with anti-pyretics for elderly persons with fever due to meningitis
- Relieve aches/pains with analgesics for elderly persons with aches due to meningitis
- Provision of anti-emetics for elderly persons with vomiting due to meningitis
- Nutritional support for elderly persons with meningitis
- Long course therapy for tuberculous meningitis in elderly persons as per guidelines
- Treatment of non-infectious meningitis depending on the cause e.g. Use of corticosteroids for meningitis due to auto-immune diseases
- Treatment of specific cancer for cancer induced meningitis.
- Managmnet of all causes of meningitis as though they are bacterial meningitis until proven otherwise.
- Management of any complications of meningitis in elderly persons e.g. seizures, raised intra-cranial pressure.
- ICU services for management of meningitis complications in elderly persons
|
|
Condition: Whooping Cough
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and Clinical examination
- Supportive management
- Administration of antibiotics
- Inpatient services
- Referral to specialised hospital for severely ill eg for ICU services for severely ill
|
|
< 5 years
|
|
|
- Antibiotics
- Antipyretics
- Hydration
- Nutritional support
- Vitamin A
|
|
5 - 11 years
|
|
|
- Antibiotics if indicated
- Antipyretics
- Hydration
- Nutritional support
- Vitamin A
|
|
12 - 24 years
|
|
|
- Physical and Clinical examination
-
- Anti-microbial therapy
- Supportive management
- Management of any complications e.g rib fracture, syncope, abdominal hernia or other complications from the severe, chronic cough
- Hospitalization for patients at risk of severe pertussis/and complication
- Rweferral to specialised hospitals for further managemnet eg ICU services for severe illness
- Laboratory tests,B pertussis, culture, polymerase chain reaction (PCR), serologic testing and direct fluorescent antibody (DFA) testing.
- Follow up
|
|
25 - 59 years
|
|
|
- Physical and Clinical examination
-
- Anti-microbial therapy
- Supportive management
- Management of any complications e.g rib fracture, syncope, abdominal hernia or other complications from the severe, chronic cough
- Hospitalization for patients at risk of severe pertussis/and complication
- Rweferral to specialised hospitals for further managemnet eg ICU services for severe illness
- Laboratory tests,B pertussis, culture, polymerase chain reaction (PCR), serologic testing and direct fluorescent antibody (DFA) testing.
- Follow up
|
|
60+ years
|
|
|
- Physical and Clinical examination
-
- Anti-microbial therapy
- Supportive management
- Management of any complications e.g rib fracture, syncope, abdominal hernia or other complications from the severe, chronic cough
- Hospitalization for patients at risk of severe pertussis/and complication
- Rweferral to specialised hospitals for further managemnet eg ICU services for severe illness
- Laboratory tests,B pertussis, culture, polymerase chain reaction (PCR), serologic testing and direct fluorescent antibody (DFA) testing.
- Follow up
|
|
Condition: Encephalitis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Early recognition and treatment of encephalitis
- Initiate anti-microbial therapy including appropriate therapy for presumed bacterial meningitis (use antibiotics for acute bacterial meningitis
- Initiate anti-viral treatment immediately
- Initiate specific regimen after determining the etiology of encephalitis
- For Viral encephalitis use of antiviral treatment.e.g. for herpes simplex virus /Antiviral medications e.g. Acyclovir
- Antimicrobial therapy targeting the identified infectious agent,
Supportive care for severe encephalitis including Breathing assistance,
- Intravenous fluids adminstration
- Anti-inflammatory drugs administration
- Administration of Anticonvulsant medications
- Admissions for persons with encephalitis
- Management of any complications
- Prevention /or management of shock or hypertension
- Prevention/Management of seizures
- Management of hydrocephalus and increased intracranial pressure
- ICU services - Laboartory diagnostic interventions for Encephalitis including:
- Blood and urine tests - lumbar puncture (LP) -CSF culture
- Blood cultures for bacterial pathogens - Serologic tests for Toxoplasma
- Imaging such as Computerized Tomography CT - MRI
- Computerized Tomography CT
- Magnetic Resonance Imaging MRI
|
|
< 5 years
|
|
|
- Early recognition and treatment of encephalitis
- Initiate anti-viral treatment immediately
- Initiate anti-microbial therapy including appropriate therapy for presumed bacterial meningitis (use antibiotics for acute bacterial meningitis
- For Viral encephalitis use of antiviral treatment.e.g. for herpes simplex virus /Antiviral medications e.g. Acyclovir
- Initiate specific regimen after determining the etiology of encephalitis
- Antimicrobial therapy targeting the identified infectious agent,
- Supportive care for severe encephalitis including: * Breathing assistance,
- Intravenous fluids adminstration
- Anti-inflammatory drugs administration
- Administration of Anticonvulsant medications
- Admissions for persons with encephalitis
- Management of any complications
- Prevention /or management of shock or hypertension
- Prevention/Management of seizures
- Management of hydrocephalus and increased intracranial pressure
- ICU services
- Laboartory diagnostic interventions for Encephalitis including:
- Blood and urine tests- lumbar puncture (LP) -CSF culture - Blood cultures for bacterial pathogens
- Serologic tests for Toxoplasma
- Imaging such
- Computerized Tomography CT
- Magnetic Resonance Imaging MRI
|
|
5 - 11 years
|
|
|
- Early recognition and Initiate anti-viral treatment immediately
- Computerized Tomography CT
- Initiate anti-microbial therapy including appropriate therapy for presumed bacterial meningitis (use antibiotics for acute bacterial meningitis
- Initiate specific regimen after determining the etiology of encephalitis
- For Viral encephalitis use of antiviral treatment.e.g. for herpes simplex virus /Antiviral medications e.g. Acyclovir
- Antimicrobial therapy targeting the identified infectious agent,
- Supportive care for severe encephalitis including: * Breathing assistance,
- Intravenous fluids adminstration
- Anti-inflammatory drugs administration
- Administration of Anticonvulsant medications
- Admissions for persons with encephalitis
- Management of any complications
- Prevention/or management of shock or hypertension
- Prevention/Management of seizures
- Management of hydrocephalus and increased intracranial pressure
- ICU services
- Laboartory diagnostic interventions for Encephalitis including:
- Blood and urine tests
- lumbar puncture (LP)
- CSF culture
- Blood cultures for bacterial pathogens
- Serologic tests for Toxoplasma
- Imaging such as Computerized Tomography CT- MRI
- Magnetic Resonance Imaging MRI
|
|
12 - 24 years
|
|
|
- Early recognition and treatment of encephalitis
- Computerized Tomography CT
- Initiate anti-viral treatment immediately
- Initiate anti-microbial therapy including appropriate therapy for presumed bacterial meningitis (use antibiotics for acute bacterial meningitis
- Initiate specific regimen after determining the etiology of encephalitis
- For Viral encephalitis use of antiviral treatment.e.g. for herpes simplex virus /Antiviral medications e.g. Acyclovir
- Antimicrobial therapy targeting the identified infectious agent,
- Supportive care for severe encephalitis including: * Breathing assistance,
- Intravenous fluids adminstration
- Anti-inflammatory drugs administration
- Administration of Anticonvulsant medications
- Admissions for persons with encephalitis
- Management of any complications
- Prevention /or management of shock or hypertension
- Prevention/Management of seizures
- Management of hydrocephalus and increased intracranial pressure
- ICU services
- Laboartory diagnostic interventions for Encephalitis including:
- Blood and urine tests
- lumbar puncture (LP) -CSF culture
- Blood cultures for bacterial pathogens
- Serologic tests for Toxoplasma
- Imaging such as: Imaging such as Computerized Tomography CT - MRI
- Magnetic Resonance Imaging MRI
|
|
25 - 59 years
|
|
|
- Early recognition and treatment of encephalitis
- Initiate anti-viral treatment immediately
- Initiate anti-microbial therapy including appropriate therapy for presumed bacterial meningitis (use antibiotics for acute bacterial meningitis
- Initiate specific regimen after determining the etiology of encephalitis
- For Viral encephalitis use of antiviral treatment.e.g. for herpes simplex virus /Antiviral medications e.g. Acyclovir
- Antimicrobial therapy targeting the identified infectious agent,
- Supportive care for severe encephalitis including: * Breathing assistance,
- Intravenous fluids adminstration
- Anti-inflammatory drugs administration
- Administration of Anticonvulsant medications
- Admissions for persons with encephalitis
- Management of any complications
- Prevention /or management of shock or hypertension
- Prevention/Management of seizures
- Management of hydrocephalus and increased intracranial pressure
- ICU services
- Laboartory diagnostic interventions for Encephalitis including:
- Blood and urine tests - lumbar puncture (LP) -CSF culture - Blood cultures for bacterial pathogens - Serologic tests for Toxoplasma
- Physical and clinical examination
- Imaging such as: - Imaging such as Computerized Tomography CT - MRI
- Computerized Tomography CT
- Magnetic Resonance Imaging MRI
|
|
60+ years
|
|
|
- Early recognition and treatment of encephalitis
- Initiate anti-viral treatment immediately
- Initiate anti-microbial therapy including appropriate therapy for presumed bacterial meningitis (use antibiotics for acute bacterial meningitis
- Initiate specific regimen after determining the etiology of encephalitis
- For Viral encephalitis use of antiviral treatment.e.g. for herpes simplex virus /Antiviral medications e.g. Acyclovir
- Antimicrobial therapy targeting the identified infectious agent,
- Supportive care for severe encephalitis including: * Breathing assistance,
- Intravenous fluids adminstration
- Anti-inflammatory drugs administration
- Administration of Anticonvulsant medications
- Admissions for persons with encephalitis
- Management of any complications
- Prevention /or management of shock or hypertension
- Prevention/Management of seizures
- Management of hydrocephalus and increased intracranial pressure
- ICU services
- Laboartory diagnostic interventions for Encephalitis including:
- Blood and urine tests
- lumbar puncture (LP)
- CSF culture
- Blood cultures for bacterial pathogens - Serologic tests for Toxoplasma - Magnetic Resonance Imaging MRI
- Imaging such as: - Computerized Tomography - CT - MRI
|
|
Condition: Measles
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Immunoglobulin/measles antibodies administration for post exposure for Pregnant women
- Fetal monitoring
- Follow up of the newborns and manage any complications e.g. Low birth weight, babies born prematurely
|
|
< 5 years
|
|
|
- Antibiotics when indicated
- Antipyretics
- Vitamin A
- Hydration
|
|
5 - 11 years
|
|
|
- Antibiotics if indicated
- Antipyretics
- Hydration
|
|
12 - 24 years
|
|
|
- Post exposure vaccination for unvaccinated contacts (within 72 hours of exposure to measles virus)
- Relieve common symptoms of measles in adolescents
- Fever
- Cough
- Blocked nose
- Conjunctivitis
- Sore mouth
- Provide nutritional support
- Appropriate Antibiotics administration for any secondary infection e.g. pneumonia
- Responses for AEFI
- Identify and manage any complications as per guidelines e.g. pneumonia,croup,diarrhea,malnutrition, otitis media,mouth ulcers,eye complications (conjunctivitis),laryngitis,febrile seizures,encephalitis
- Intensive care services for adolescents with severe complications of measles
- Follow up
- N/B Investigations-carry out necessary confirmatory tests for measles if need be (blood tests,throat swab; urine sample)
|
|
25 - 59 years
|
|
|
- Post exposure vaccination for unvaccinated contacts (within 72 hours of exposure to measles virus)
- Management of measles complications in adults including;
- otitis media,conjunctivitis, pneumonia, croup, seizures, encephalitis
- N/B Carry out necessary confirmatory tests for measles if need be (blood tests,throat swab, urine sample)
|
|
60+ years
|
|
|
- Isolation of patients with measles to prevent spread
|
|
Condition: Trichomoniasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Diagnostic tests
- Swab test: Vaginal swab is cultured for identifying the causative of infection.
- Antigen test: Rapid test in which antibody reacts with antigen forming a color on positive test.
- DNA test: Nucleic acid from vaginal swab undergoes PCR to detect nucleic acid.
- Wet prep: Fluid from vagina may be examined under microscope.
- Treatment with metronidazole or tindazole
- Treatmnet of sexual partners
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- Diagnostic tests
- Swab test: Vaginal swab is cultured for identifying the causative of infection.
- Antigen test: Rapid test in which antibody reacts with antigen forming a color on positive test.
- DNA test: Nucleic acid from vaginal swab undergoes PCR to detect nucleic acid.
- Wet prep: Fluid from vagina may be examined under microscope.
- Treatment with metronidazole or tindazole
- Treatmnet of sexual partners
|
|
12 - 24 years
|
|
|
- Diagnostic tests
- Swab test: Vaginal swab is cultured for identifying the causative of infection.
- Antigen test: Rapid test in which antibody reacts with antigen forming a color on positive test.
- DNA test: Nucleic acid from vaginal swab undergoes PCR to detect nucleic acid.
- Wet prep: Fluid from vagina may be examined under microscope.
- Urine test: For men, urine sample is tested to detect the presence of the parasite.
- Treatment with metronidazole or tindazole
- Treatmnet of sexual partners
|
|
25 - 59 years
|
|
|
- Diagnostic tests
- Swab test: Vaginal swab is cultured for identifying the causative of infection.
- Antigen test: Rapid test in which antibody reacts with antigen forming a color on positive test.
- DNA test: Nucleic acid from vaginal swab undergoes PCR to detect nucleic acid.
- Wet prep: Fluid from vagina may be examined under microscope.
- Urine test: For men, urine sample is tested to detect the presence of the parasite.
- Treatment with metronidazole or tindazole
- Treatmnet of sexual partners
|
|
60+ years
|
|
|
|
|
Condition: Tuberculosis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Confirmation of diagnosis using acid fast stain and culture of sputum
- Treatment of confirmed TB cases with anti TB medication using Direct Observed Therapy (DOT)
- Treatment with anti-TB medication
- Direct Observed Therapy (DOT) to promote adherence to medication
- Managment of TB/HIV co-infection
- Initiation of co-trimoxazole preventive therpay for TB/HIV co-ifection
- ART therapy for TB/HIV co-infection
- TB drugs refill
- Management of Multi -drug resistance TB
- Sputum smear /Stain and culture of sputum
- TB skin test
- HIV Counseling and Testing for confirmed TB cases
- Monitoring of TB complications
|
|
< 5 years
|
|
|
- Directly Observed Therapy (DOTs)
- Manage adverse reactions and complications
|
|
5 - 11 years
|
|
|
- Directly Observed Therapy (DOTs)
- Self-administrative therapy (SAT) to those with good adherence
- ART therapy for TB/HIV co-infection
- Referral of people living HIV for regular screening and possible TPT * TB drugs refill for SAT
- Trace and follow up of defaulters
- Referral of people with adverse reactions and complications
|
|
12 - 24 years
|
|
|
- Directly Observed Therapy (DOTs)
- Self-administrative therapy (SAT) to those with good adherence
- ART therapy for TB/HIV co-infection
- Referral of people living HIV for regular screening and possible TPT * TB drugs refill for SAT
- Trace and follow up of defaulters
- Manage adverse reactions and complications
|
|
25 - 59 years
|
|
|
- Directly Observed Therapy (DOTs)
- Self-administrative therapy (SAT) to those with good adherence
- ART therapy for TB/HIV co-infection
- Referral of people living HIV for regular screening and possible TPT * TB drugs refill for SAT
- Trace and follow up of defaulters
- Manage adverse reactions and complications
|
|
60+ years
|
|
|
- Directly Observed Therapy (DOTs)
- Self-administrative therapy (SAT) to those with good adherence
- ART therapy for TB/HIV co-infection
- Referral of people living HIV for regular screening and possible TPT * TB drugs refill for SAT
- Trace and follow up of defaulters
- Referral of people with adverse reactions and complications
|
|
Condition: Syphilis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Antibiotics
- Referral to the next higher level for corrective surgery
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
Treatment with Penicillin
|
|
12 - 24 years
|
|
|
Treatment with PenicillinTreatment of sex partners
|
|
25 - 59 years
|
|
|
Treatment with PenicillinTreatment of sex partners
|
|
60+ years
|
|
|
Treatment with PenicillinTreatment of sex partners
|
|
Condition: Other STDs
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Appropriate treatment for condition Concomitant treatment for Chlamydia and Gonorrhea
- Treatment of sex partners of parents/guardians
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- History and physical examination for STI and reproductive tract infections
- Basic laboratory tests for STI
- Etiologic diagnosis and treatment of STIs
- Counselling on partner notification, diagnosis and treatment
- Information on treatment compliance and use of condom
- Referral for management of complications of STIs
|
|
12 - 24 years
|
|
|
- Appropriate treatment for condition Concomitant treatment for Chlamydia and Gonorrhea
- Treatment of sex partners
- Conduct investigative laboratory tests Such as chlamydia, RPR test for syphilis
- Syndromic management of STIs with microscope according to guidelines
- Develop National STI and mentoring program to support clinicians on-site with diagnosis, treatment, record keeping and greater integration of STI and HIV services
- Promote regular inquiries of STI symptoms at ANC and general outpatient visits, using the syndromic method of STI management.
|
|
25 - 59 years
|
|
|
- History and physical examination for STI and reproductive tract infections
- Basic laboratory tests for STI
- Etiologic diagnosis and treatment of STIs
- Counselling on partner notification, diagnosis and treatment
- Information on treatment compliance and use of condom
- Referral for management of complications of STIs
|
|
60+ years
|
|
|
- Appropriate treatment for condition Concomitant treatment for Chlamydia and Gonorrhoea
- Treatment of sex partners
- Conduct investigative laboratory tests Such as chlamydia, RPR test for syphilis
- Syndromic management of STIs with microscope according to guidelines
- Develop National STI and mentoring program to support clinicians on-site with diagnosis, treatment, record keeping and greater integration of STI and HIV services
- Promote regular inquiries of STI symptoms at ANC and general outpatient visits, using the syndromic method of STI management.
|
|
Condition: HIV/AIDS
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Partner notification and expedited treatment for common STIs, /HIV
- Provider initiated counselling and testing
- HIV testing
- Diagnostics
- Blood tests
- CD4 count
- Imaging -X-rays
- Microscopy culture and sensitivity
- Syndromic management of STIs
- Clinical staging of HIV
- Chemotherapy for STIs that have progressed into cancer
- Radiotherapy for STIs that have progressed into cancer
- Defaulter tracking
- Management of opportunistic infections
- Chronic diarrhoea
- Oral Candidiasis
-Oesophageal Candidiasis
- Bacterial infections
- PCP
- Toxoplasmosis
- TB
- Extra pulmonary.
- Cytomegalovirus Infection
- Kaposi’s sarcoma
- Lymphoma and other HIV related malignancies.
- Screening for TB and other opportunistic infections
- Management of TB co-infection
- Management of advanced HIV disease and complications
- Management of any complications
- Management for sexual violence cases and referral to support services
8 Treatment literacy /adherence counselling
- Supportive management
- Nutritional support /Supplements
- Monitoring adherence to prescribed medications
- ART initiation services
- ART Monitoring
- ART refills
- Referral and linkages
|
|
< 5 years
|
|
|
- First-line antiretroviral therapy
- Second-line antiretroviral therapy
- Manage moderate to severe adverse reactions * Viral load monitoring
- Treat moderate to severe OIs
- Treat TB/HIV co-infection
- Manage co-morbidities
- Referral to higher level for to non-responders
|
|
5 - 11 years
|
|
|
- First-line antiretroviral therapy
- Second-line antiretroviral therapy
- Co-trimoxazole prophylaxis
- TB preventive therapy
- Manage moderate to severe adverse reactions * Viral load monitoring
- Treat moderate to severe OIs
- Treat TB
- Manage co-morbidities
- Referral to higher level for to non-responders
|
|
12 - 24 years
|
|
|
- First-line antiretroviral therapy
- Second-line antiretroviral therapy
- Co-trimoxazole prophylaxis
- TB preventive therapy
- Fluconazole pre-emptive therapy
- Manage moderate to severe adverse reactions * Viral load monitoring
- Treat moderate to severe OIs
- Treat TB
- Manage co-morbidities (viral hepatitis, NCDs)
- Referral to higher level for to non-responders
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- First-line antiretroviral therapy
- Second-line antiretroviral therapy
- Manage moderate to severe adverse reactions * Viral load monitoring
- Treat moderate to severe OIs
- Treat TB/HIV co-infection
- Manage co-morbidities (viral hepatitis, NCDs)
- Referral to higher level for to non-responders
|
|
Condition: Gonorrhoea
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Treatment with single dose of Ceftriaxone or Cefixime
- Concomitant treatment for ChlamydiaTreatment of sex partners treatment of Gonococcal conjunctivitis in newborns with Tetracycline ointments or drops and saline irrigation
- Systemic treatment of newborns with Gonococcal conjunctivitis with IM Ceftriaxone
|
|
< 5 years
|
|
|
- Treatment of Gonococcal conjunctivitis in newborns with Tetracycline and saline irrigation
- Systemic treatment of newborns with Gonococcal conjunctivitis with IM Ceftriaxone
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Treatment with single dose of Ceftriaxone or CefiximeConcomitant treatment for Chlamydia
- Treatment of sex partners
|
|
60+ years
|
|
|
|
|
Condition: Genital herpes
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Treatment with Acyclovir, valacyclovir or famciclovir
- Treatment of sex partners
|
|
25 - 59 years
|
|
|
- Treatment with Acyclovir, valacyclovir or famciclovir
- Treatment of sex partners
|
|
60+ years
|
|
|
- Treatment with Acyclovir, valacyclovir or famciclovir
- Treatment of sex partners
|
|
Condition: Diarrhoeal diseases
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Intravenous hydration
- Antibiotics to treat bacterial infections
- Zinc supplements
|
|
< 5 years
|
|
|
- Intravenous hydration
- Antibiotics to treat bacterial infections
- Zinc supplements
|
|
5 - 11 years
|
|
|
- Intravenous hydration
- Antibiotics to treat bacterial infections
- Zinc supplements
|
|
12 - 24 years
|
|
|
- Intravenous hydration
- Antibiotics to treat bacterial infections
- Zinc supplements
|
|
25 - 59 years
|
|
|
- Intravenous hydration
- Antibiotics to treat bacterial infections
- Zinc supplements
|
|
60+ years
|
|
|
- Intravenous hydration
- Antibiotics to treat bacterial infections
- Zinc supplements
|
|
Condition: Chlamydia
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Diagnostics tests
- Swab test for culturing or antigen testing for chlamydia especially in pregnant women
- Treatment of confirmed Chlamydia infection antibiotics
- Treatment of Chlamydia conjunctivitis in newborns with antibiotics (topical or systemic as indicated)
- Guidance on avoidance of sex until completion of treatment course
- Referral
|
|
< 5 years
|
|
|
- Physical and clinical examination
- Treatment of Chlamydia conjunctivitis in infants with antibiotics
- Referral as may be indicated
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Physical and clinical examination
- Diagnostics tests
- Swab test for culturing or antigen testing for chlamydia especially in women (female adolescents in this case)
- Urine culture-especially in men (male aldolescents in this case)
- Treatment of confirmed Chlamydia infection antibiotics
- Guidance on avoidance of sex until completion of treatment course
- Referral
|
|
25 - 59 years
|
|
|
- Physical and clinical examination
- Diagnostics tests
- Swab test for culturing or antigen testing for chlamydia especially in women (adult women in this case)
- Urine culture-especially in men (adult men in this case)
- Treatment of confirmed Chlamydia infection antibiotics
- Guidance on avoidance of sex until completion of treatment course
- Referral
|
|
60+ years
|
|
|
- Physical and clinical examination
- Diagnostics tests
- Swab test for culturing or antigen testing for chlamydia especially in women (elderly women in this case)
- Urine culture-especially in men (elderly men in this case)
- Treatment of confirmed Chlamydia infection antibiotics
- Guidance on avoidance of sex until completion of treatment course
- Referral
|
|
Condition: Dengue
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
- In addition to primary care interventions
- Conduct virus isolation, genome detection, NS1 Ag, IgA and IgM antigens by rapid test, ELISA and in addition for IgA by IHS and neutralization assays.
- Implement case management decisions for severe dengue with warning signs (Group B and C) including treatment of profound/compensated shock, electrolyte imbalances, metabolic acidosis, ensure glucose control, hemorrhagic complications
|
|
5 - 11 years
|
|
|
In addition to primary care interventions
- Conduct virus isolation, genome detection, NS1 Ag, IgA and IgM antigens by rapid test, ELISA and in addition for IgA by IHS and neutralization assays.
- Implement case management decisions for severe dengue with warning signs (Group B and C) including treatment of profound/ compensated shock, electrolyte imbalances, metabolic acidosis, ensure glucose control, hemorrhagic complications
|
|
12 - 24 years
|
|
|
- In addition to primary care interventions
- Conduct virus isolation, genome detection, NS1 Ag, IgA and IgM antigens by rapid test, ELISA and in addition for IgA by IHS and neutralization assays.
- Implement case management decisions for severe dengue with warning signs (Group B and C) including treatment of profound/ compensated shock, electrolyte imbalances, metabolic acidosis, ensure glucose control, hemorrhagic complications
|
|
25 - 59 years
|
|
|
- In addition to primary care interventions
- Conduct virus isolation, genome detection, NS1 Ag, IgA and IgM antigens by rapid test, ELISA and in addition for IgA by IHS and neutralization assays.
- Implement case management decisions for severe dengue with warning signs (Group B and C)including treatment of profound/compensated shock, electrolyte imbalances, metabolic acidosis, ensure glucose control, hemorrhagic complications
|
|
60+ years
|
|
|
- In addition to primary care interventions
- Conduct virus isolation, genome detection, NS1 Ag, IgA and IgM antigens by rapid test, ELISA and in addition for IgA by IHS and neutralization assays.
- Implement case management decisions for severe dengue with warning signs (Group B and C) including treatment of profound/ compensated shock, electrolyte imbalances, metabolic acidosis, ensure glucose control, hemorrhagic complications
|
|
Condition: Lymphatic filariasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- Single dose preventive chemotherapy with Albendazole (Alb), Ivermectin (IV) or Diethylcarbamazine (DEC)
- Management of Hydrocele through surgery
|
|
12 - 24 years
|
|
|
- Single dose preventive chemotherapy with Albendazole (Alb), Ivermectin (IV) or Diethylcarbamazine (DEC)
- Management of Hydrocele through surgery
|
|
25 - 59 years
|
|
|
- Single dose preventive chemotherapy with Albendazole (Alb), Ivermectin (IV) or Diethylcarbamazine (DEC)
- Management of Hydrocele through surgery
|
|
60+ years
|
|
|
- Management of Hydrocele through surgery
- Single dose preventive chemotherapy with Albendazole (Alb), Ivermectin (IV) or Diethylcarbamazine (DEC)
|
|
Condition: Diphtheria
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Clinical examination and diagnosis of diptheria in pregnant women
Supportive management to pregnant mothers with diphtheria to/Relieve common symptoms
- Relieve fever with anti pyretics/analgesics such as paracetamol and ibuprofen
- Immunization with diphtheria toxoid vaccine for pregnant mothers
- Fetal monitoring
- Provide nutritional support for the adults with diphtheria
- Monitoring and Management of complications of diphtheria in pregnant women such as shortness of breath/breathing difficulties
- Management of neonates with low birth weights, preterm babies/as a result of diphtheria
|
|
< 5 years
|
|
|
-
- Physical and Clinical examination and diagnosis of diphtheria in children under 5 years of age. -based on signs and symptoms of diphtheria including; - Fever
- Isolation. Respiratory droplet isolation of children under 5s with respiratory diphtheria and contact precautions for under 5s children with cutaneous diphtheria
- Antitoxin treatment with DAT immediately diphtheria is strongly suspected in children under 5 years (without waiting for lab results)
- Antibiotic treatment (penicillin or erythromycin) to eliminate the bacteria and toxin production
- Immunization with diphtheria toxoid vaccine during convalescence for children who have not been vaccinated/have not completed the appropriate course
- Tests, nasal/pharyngeal swabs for culture
- Monitor and management of any diphtheria complications such as obstruction of the airways, systemic diphtheria -to the heart, kidney or peripheral nerves
- Emergency management for diphtheria complication such as airway obstructions
|
|
5 - 11 years
|
|
|
- Physical and Clinical examination and diagnosis of diphtheria in children under 5 years of age. -based on signs and symptoms of diphtheria including; - Fever
- Tests, Nasal/pharyngeal swabs for culture
- Antitoxin treatment with DAT immediately diphtheria is strongly suspected in school age children (without waiting for lab results)
- Antibiotic treatment (penicillin or erythromycin) to eliminate the bacteria and toxin production
- Immunization with diphtheria toxoid vaccine during convalescence for school age children who are immunised/have not completed the appropriate course
- Isolation.
Respiratory droplet isolation of school age children with respiratory diphtheria and contact precautions for those with cutaneous diphtheria
- Monitor and management of any diphtheria complications such as obstruction of the airways, systemic diphtheria -to the heart, kidney or peripheral nerves
- Emergency management for diphtheria complication such as airway obstructions
|
|
12 - 24 years
|
|
|
- History Clinical examination Isolation Respiratory droplet isolation of adolescents patients with respiratory diphtheria and contact precautions for those with cutaneous diphtheria
- Antitoxin treatment with DAT immediately diphtheria is strongly suspected in adolescents (without waiting for lab results)
- Antibiotic treatment (penicillin or erythromycin) to eliminate the bacteria and toxin production
- Immunization with diphtheria toxoid vaccine during convalescence for adolescents who have not been immunized previously/have who had not completed the appropriate course
- Tests, nasal/pharyngeal swabs for culture
- Physical and Clinical examination and diagnosis of diphtheria in children under 5 years
- Monitor and management of any diphtheria complications such as obstruction of the airways, systemic diphtheria -to the heart, kidney/peripheral nerves
of age. -based on signs and symptoms of diphtheria including; - Fever
- Emergency management for diphtheria complication such as airway obstructions
|
|
25 - 59 years
|
|
|
- Identify close contacts such as caretakers, relatives, sexual contacts, friends, Health care workers
- Monitor close contacts for signs and symptoms of diphtheria
- Prophylactic antibiotics (penicillin or erythromycin) for close contacts
- Vaccination with diphtheria toxoid-containing vaccine for unvaccinated contacts and for Under-vaccinated contacts to complete their vaccination series
- Recording and reporting of diphtheria cases through established reporting mechanisms
|
|
60+ years
|
|
|
- Tests, Nasal/pharyngeal swabs for culture
-
- Physical and Clinical examination and diagnosis of diphtheria in the elderly -based on signs and symptoms of diphtheria;
- Antitoxin treatment with DAT immediately diptheria is strongly suspected in the elderly (without waiting for lab results)
- Antibiotic treatment (penicillin or erythromycin) to eliminate the bacteria and toxin production
- Immunization with diphtheria toxoid vaccine during convalescence for elderly who had not completed the appropriate course
- Isolation. Respiratory droplet isolation of elderly patients with respiratory diphtheria and contact precautions for those with cutaneous diphtheria
- Monitor and management of any diphtheria complications such as obstruction of the airways, systemic diphtheria -to the heart, kidney or peripheral nerves
- Emergency management for diphtheria complication such as airway obstructions
|
|
Condition: Acute Hepatitis B
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Supportive management
- Healthy diet
- Optimum fluids
- Enough sleep/rest
- Relieve of pain with painkillers
- Admission for severe Acute Hepatitis B
- Anti-retroviral drugs for severe acute Hepatitis B
- Monitoring and management of any complications
|
|
< 5 years
|
|
|
- Supportive management
- Healthy diet
- Plenty of fluids
- Enough sleep/rest
- Pain reliefe
- Admission for severe Acute Hepatitis B
- Anti-retroviral drugs for severe acute Hepatitis B
- Monitoring and management of any complications
|
|
5 - 11 years
|
|
|
- Physical examination,Clinical examination and diagnosis of Hepatitis B
- Supportive management for patients with Acute Hepatitis B - Provision of Healthy diet - Plenty of fluids - Encourage Exercises - Encourage the patient with Hepatitis B to have Enough sleep/rest
- Relieve of pain with painkillers
- Admission for patient with severe Acute Hepatitis B
- Administer anti-retroviral drugs for severe acute Hepatitis B to prevent complications
- Monitoring and management of any complications including acute Liver failure
- Follow up
- Investigations
- Blood tests to detect Hepatitis B surface antigen (HBsAg)
- Serum immunoglobulin M (IgM)Test for Chronic Hepatitis B indicated by persistent Hepatitis B surface antigen for at least 6 months - Test for Hepatitis A and C - Liver ultrasound - Liver Biopsy
|
|
12 - 24 years
|
|
|
- Physical examination,Clinical examination and diagnosis of Hepatitis B
- Supportive management for patients with Acute Hepatitis B
- Provision of Healthy diet - Plenty of fluids - Encourage Exercises-
- Encourage the patient with Hepatitis B to have Enough sleep/rest
- Relieve of pain with painkillers
- Admission for patient with severe Acute Hepatitis B
- Administer anti-retroviral drugs for severe acute Hepatitis B to prevent complications
- Monitoring and management of any complications including acute Liver failure
- Follow up
- Investigations
- Blood tests to detect Hepatitis B surface antigen (HBsAg)
- Serum immunoglobulin M (IgM)Test for Chronic Hepatitis B indicated by persistent Hepatitis B surface antigen for at least 6 months - Test for Hepatitis A and C - Liver ultrasound - Liver Biopsy
|
|
25 - 59 years
|
|
|
- Physical examination,Clinical examination and diagnosis of Hepatitis B
- Supportive management for patients with Acute Hepatitis B - Provision of Healthy diet - Plenty of fluids - Encourage Exercises-
- Encourage the patient with Hepatitis B to have Enough sleep/rest
- Relieve of pain with painkillers
- Admission for patient with severe Acute Hepatitis B
- Administer anti-retroviral drugs for severe acute Hepatitis B to prevent complications
- Monitoring and management of any complications including acute Liver failure
- Follow up
- Investigations
- Blood tests to detect Hepatitis B surface antigen (HBsAg)
- Serum immunoglobulin M (IgM)Test for Chronic Hepatitis B indicated by persistent Hepatitis B surface antigen for at least 6 months - Test for Hepatitis A and C - Liver ultrasound - Liver Biopsy
|
|
60+ years
|
|
|
- Physical examination,Clinical examination and diagnosis of Hepatitis B
- Supportive management for patients with Acute Hepatitis B
- Provision of Healthy diet - Plenty of fluids - Encourage Exercises-
- Encourage the patient with Hepatitis B to have Enough sleep/rest
- Relieve of pain with painkillers
- Admission for patient with severe Acute Hepatitis B
- Administer anti-retroviral drugs for severe acute Hepatitis B to prevent complications
- Monitoring and management of any complications including acute Liver failure
- Follow up
- Investigations
- Blood tests to detect Hepatitis B surface antigen (HBsAg)
- Serum immunoglobulin M (IgM)Test for Chronic Hepatitis B indicated by persistent Hepatitis B surface antigen for at least 6 months - Test for Hepatitis A and C - Liver ultrasound - Liver Biopsy
|
|
Condition: Hepatitis A
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examinationRelieve any symptom -fever, dehydration i.e.(no specific medicines except to relive symptoms)
- Relieve any symptom -fever, dehydration i.e.(no specific medicines except to relive symptoms)
- Investigations
- Blood test -To detect HAV-specific immunoglobulin G (IgM) antibodies in the blood
- Reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis A virus RNA
- Liver function tests
- Test also for hepatitis B and C
- Monitor and management of complications the main one being fulminant hepatitis (acute liver failures
|
|
< 5 years
|
|
|
- History taking & Clinical examination
- Relieve any symptom -fever, dehydration i.e.(no specific medicines except to relive symptoms)
- Investigations :-
- Blood test - To detect HAV-specific immunoglobulin G (IgM) antibodies in the blood * Reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis A virus
- RNA - Liver function tests
- Test also for hepatitis B and C
- Monitor and management of complications the main one being fulminant hepatitis (acute liver failure)
|
|
5 - 11 years
|
|
|
- Physical and Clinical examination
- Relieve any symptom -fever, dehydration i.e. (no specific medicines except to relive symptoms)
- Investigations;-
- Blood test -To detect HAV-specific immunoglobulin G (IgM) antibodies in the blood -
- Reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis A virus RNA
- Liver function tests
- Test also for hepatitis B and C
- Monitor and management of complications the main one being fulminant hepatitis (acute liver failure)
|
|
12 - 24 years
|
|
|
- Physical and Clinical examination
- Relieve any symptom -fever, dehydration i.e.(no specific medicines except to relive symptoms)
- Investigations
- Blood test -To detect HAV-specific immunoglobulin G (IgM) antibodies in the blood
- Reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis A virus RNA
- Liver function tests
- Test also for hepatitis B and C
- Monitor and management of complications the main one being fulminant hepatitis (acute liver failure)
|
|
25 - 59 years
|
|
|
- Physical and Clinical examination
- Relieve any symptom -fever, dehydration i.e.(no specific medicines except to relive symptoms)
- Investigations
- Blood test -To detect HAV-specific immunoglobulin G (IgM) antibodies in the blood
- Reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis A virus RNA
- Liver function tests
- Test also for hepatitis B and C
- Monitor and management of complications the main one being fulminant hepatitis (acute liver failure)
|
|
60+ years
|
|
|
- Physical and Clinical examination
- Relieve any symptom -fever, dehydration i.e.(no specific medicines except to relieve symptoms
Investigations ;-
- Blood test -To detect HAV-specific immunoglobulin G (IgM) antibodies in the blood * Reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis A virus RNA
- Liver function tests
- Test also for hepatitis B and C
- Monitor and management of complications the main one being fulminant hepatitis (acute liver failure)
|
|
Condition: Hepatitis E
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- N/b There is no specific treatment capable of altering the course of acute hepatitis E.; usually self-limiting disease
- Supportive treatment including; - proper nutrition,Adequate rest
- Monitoring and management of any complications main one being fulminant hepatitis (acute liver failure)
- Relieving fever through use of pain killers
- Admission/hospitalization for symptomatic pregnant women.
- Physical and clinical examination,Diagnosis based on
- Strong link in appropriate epidemiology settings, e.g. when several cases occur in localities in known disease-endemic areas, or in settings with risk of water contamination.
- Rule out hepatitis A
- Blood tests for detection of specific IgM antibodies to the virus for definitive diagnosis.
|
|
< 5 years
|
|
|
- Physical and clinical examination
- Supportive treatment including: proper nutrition, Adequate rest
- Admissions for children who may develop severe Hepatitis E (usually due to co-infection with Hep.A)
- Diagnosis based on
- Strong link in appropriate epidemiology settings, e.g. when several cases occur in localities in known disease-endemic areas, or in settings with risk of water contamination.
- Relieving fever through use of pain killers
- Monitoring and management of any complications main one being fulminant hepatitis (acute liver failure)
- Rule out hepatitis A
- Blood tests for detection of specific IgM antibodies to the virus for definitive diagnosis.
|
|
5 - 11 years
|
|
|
- N/b There is no specific treatment capable of altering the course of acute hepatitis E.; usually self-limiting disease
- Supportive treatment including:
- proper nutrition,
- Adequate rest
- relieving fever through use of pain killers
- Physical and clinical examination
- Diagnosis based on Strong link in appropriate epidemiology settings, e.g. when several cases occur in localities in known disease-endemic areas, or in settings with risk of water contamination.
- Rule out hepatitis A
- Blood tests for detection of specific IgM antibodies to the virus for definitive diagnosis.
|
|
12 - 24 years
|
|
|
- Physical and clinical examination,Diagnosis based on Strong link in appropriate epidemiology settings, e.g. when several cases occur in localities in known disease-endemic areas, or in settings with risk of water contamination.
- Supportive treatment including:
- proper nutrition, * Adequate rest
- Relieving fever through use of pain killers
- Monitoring and management of any complications main one being fulminant hepatitis (acute liver failure)
- N/b There is no specific treatment capable of altering the course of acute hepatitis E.; usually self-limiting disease
- Rule out hepatitis A
- Blood tests for detection of specific IgM antibodies to the virus for definitive diagnosis.
|
|
25 - 59 years
|
|
|
- Monitoring and management of any complications main one being fulminant hepatitis (acute liver failure)
- N/b There is no specific treatment capable of altering the course of acute hepatitis E.; usually self-limiting disease
- Supportive treatment including:
- proper nutrition,
- Adequate rest
- relieving fever through use of pain killers
- Physical and clinical examination
- Diagnosis based on Strong link in appropriate epidemiology settings, e.g. when several cases occur in localities in known disease-endemic areas, or in settings with risk of water contamination.
- Rule out hepatitis A
- Blood tests for detection of specific IgM antibodies to the virus for definitive diagnosis.
|
|
60+ years
|
|
|
- Monitoring and management of any complications main one being fulminant hepatitis (acute liver failure)
- N/b There is no specific treatment capable of altering the course of acute hepatitis E.; usually self-limiting disease
- Supportive treatment including:
- proper nutrition,
- Adequate rest
- relieving fever through use of pain killers
- Physical and clinical examination
- Diagnosis based on Strong link in appropriate epidemiology settings, e.g. when several cases occur in localities in known disease-endemic areas, or in settings with risk of water contamination.
- Rule out hepatitis A
- Blood tests for detection of specific IgM antibodies to the virus for definitive diagnosis.
|
|
Condition: Diabetes mellitus
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Pre-natal screening for Gestational diabetes
- Management of Gestational diabetes and pre-existing diabetes through advice on Lifestyle change including.
- healthy balanced diet/nutritional therapy - regular daily physical activity.
- Weight management depending on pregestational weight
- Medications/use of Insulin for treating hyperglycemia in gestational diabetes mellitus as it does not cross the placenta
- Management of pre-existing diabetes in pregnant women through use of insulin
- Monitoring and prevention of pre-eclampsia in pregnant women with diabetes (use low dose aspirin 60–150 mg/day - Foetal monitoring
- Monitoring of the neonates blood sugar after delivery
- Postpartum Follow-up
|
|
< 5 years
|
|
|
- Physical and Clinical examination
- Random and fasting blood sugars for diagnosis of type 1 diabetes
- Advice to parents on healthy foods for the child with diabetes
- Guidance and encouraging Exercise regularly
- Management of type 1 diabetes with insulin injection
- Frequent blood sugar monitoring and blood glucose control
- Recognition and management of acute diabetic emergencies (hypoglycaemeia and hyperglycaemia emergencies)
- Monitoring and control of blood pressure
- Monitoring and management of any complications including
- Screening for and management of blood lipid (to regulate cholesterol levels)
- screening for early signs of diabetes-related kidney disease and treatment
- Regular examination of the feet and management of any foot ulcers to prevent diabetic foot screening and treatment for retinopathy
- Follow up
|
|
5 - 11 years
|
|
|
- Healthy diet
- Physical activity
- Insulin
- Monitoring glycaemic control
- Prevent and treat diabetic ketoacidosis
|
|
12 - 24 years
|
|
|
- Healthy diet
- Physical activity
- Insulin
- Monitoring glycaemic control
- Prevent and treat diabetic ketoacidosis
|
|
25 - 59 years
|
|
|
- Lifestyle management
- Medical nutrition therapy
- Oral glucose-lowering medications
- Insulin
- Monitoring glycaemic control
- Detect and manage DM-specific complications
|
|
60+ years
|
|
|
- Lifestyle management
- Medical nutrition therapy
- Oral glucose-lowering medications
- Insulin
- Monitoring glycaemic control
- Detect and manage DM-specific complications
|
|
Condition: Rabies
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Recognition and categorization of animal bite exposures categorized as carrying a risk of developing rabies which include: if the biting mammal is a known rabies reservoir or vector species, the exposure occurs in a geographical area where rabies is still present, the animal looks sick or displays abnormal behavior, a wound or mucous membrane was contaminated by the animal’s saliva, the bite was unprovoked, the animal has not been vaccinated, The vaccination status of the suspect animal is questionable
- Immediate post exposure prophylaxis of the pregnant women assessed as carrying a risk of developing rabies;
- Extensive washing ; flushing and local treatment of the bite wound or scratch as soon as possible after a suspected exposure;
- Administration of rabies vaccine
- the administration of rabies immunoglobulin (RIG), if indicated.
- Relieve of any other symptoms such as pain with analgesics
- Foetal monitoring
- Monitor and manage any complications depending on the two forms of rabies – such as cardiopulmonary arrest as a result of furious rabies or muscle paralysis and coma due to paralytic rabies
- ICU services for patients with complications e.g. those in coma
- Integrated bite case management/alert the veterinary services to remove the biting animal from the community/quarantined
|
|
< 5 years
|
|
|
- Physical and clinical examination,
- Recognition and categorization of animal bite exposures categorized as carrying a risk of developing rabies which include:if the biting mammal is a known rabies reservoir or vector species, the exposure occurs in a geographical area where rabies is still present, the animal looks sick or displays abnormal behavior, a wound or mucous membrane was contaminated by the animal’s saliva; the bite was unprovoked, the animal has not been vaccinated, The vaccination status of the suspect animal is questionable
- Immediate post exposure prophylaxis of all categorized exposures assessed as carrying a risk of developing rabies;
- Extensive washing; flushing and local treatment of the bite wound or scratch as soon as possible after a suspected exposure; Administration of rabies vaccine the administration of rabies immunoglobulin (RIG), if indicated.
- Relieve of any other symptoms such as pain with analgesics
- Monitor and manage any complications depending on the two forms of rabies – such as cardiopulmonary arrest as a result of furious rabies or muscle paralysis and coma due to paralytic rabies
- ICU services for patients with complications e.g. those in coma
- Integrated bite case management/alert the veterinary services to remove the biting animal from the community/quarantined.
|
|
5 - 11 years
|
|
|
- Physical and clinical examination,
- Recognition and categorization of animal bite exposures categorized as carrying a risk of developing rabies which include:if the biting mammal is a known rabies reservoir or vector species, the exposure occurs in a geographical area where rabies is still present,the animal looks sick or displays abnormal behavior, a wound or mucous membrane was contaminated by the animal’s saliva; the bite was unprovoked, the animal has not been vaccinated, The vaccination status of the suspect animal is questionable
- Immediate post exposure prophylaxis of all categorise exposures assessed as carrying a risk of developing rabies;
- Extensive washing; flushing and local treatment of the bite wound or scratch as soon as possible after a suspected exposure, Administration of rabies vaccine, the administration of rabies immunoglobulin (RIG), if indicated.
- Relieve of any other symptoms such as pain with analgesics
- Monitor and manage any complications depending on the two forms of rabies – such as cardiopulmonary arrest as a result of furious rabies or muscle paralysis and coma due to paralytic rabies
- ICU services for patients with complications e.g. those in coma
- Integrated bite case management/alert the veterinary services to remove the biting animal from the community/quarantined
|
|
12 - 24 years
|
|
|
- Physical and clinical examination,
- Recognition and categorization of animal bite exposures categorized as carrying a risk of developing rabies which include: * * if the biting mammal is a known rabies reservoir or vector species, the exposure occurs in a geographical area where rabies is still present, the animal looks sick or displays abnormal behavior, a wound or mucous membrane was contaminated by the animal’s saliva; the bite was unprovoked, the animal has not been vaccinated, The vaccination status of the suspect animal is questionable
- Immediate post exposure prophylaxis of all categorized exposure assessed as carrying a risk of developing rabies
- Extensive washing; flushing and local treatment of the bite wound or scratch as soon as possible after a suspected exposure ,Administration of rabies vaccine, the administration of rabies immunoglobulin (RIG), if indicated.
- Relieve of any other symptoms such as pain with analgesics
- Monitor and manage any complications depending on the two forms of rabies – such as cardiopulmonary arrest as a result of furious rabies or muscle paralysis and coma due to paralytic rabies
- ICU services for patients with complications e.g. those in coma
- Integrated bite case management/alert the veterinary services to remove the biting animal from the community/quarantine the animal
|
|
25 - 59 years
|
|
|
- Physical and clinical examination,
- Recognition and categorization of animal bite exposures categorized as carrying a risk of developing rabies which include: if the biting mammal is a known rabies reservoir or vector species, the exposure occurs in a geographical area where rabies is still present, the animal looks sick or displays abnormal behavior, a wound or mucous membrane was contaminated by the animal’s saliva; the bite was unprovoked, the animal has not been vaccinated, The vaccination status of the suspect animal is questionable
- Immediate post exposure prophylaxis of all categorized exposures assessed as carrying a risk of developing rabies;
- Extensive washing; flushing and local treatment of the bite wound or scratch as soon as possible after a suspected exposure; Administration of rabies vaccine, the administration of rabies immunoglobulin (RIG), if indicated.
- Relieve of any other symptoms such as pain with analgesics
- Monitor and manage any complications depending on the two forms of rabies – such as cardiopulmonary arrest as a result of furious rabies or muscle paralysis and coma due to paralytic rabies
- ICU services for patients with complications e.g. those in coma
- Integrated bite case management/alert the veterinary services to remove the biting animal from the community/quarantined
|
|
60+ years
|
|
|
- Physical and clinical examination,
- Recognition and categorization of animal bite exposures categorized as carrying a risk of developing rabies which include:if the biting mammal is a known rabies reservoir or vector species, the exposure occurs in a geographical area where rabies is still present, the animal looks sick or displays abnormal behavior, a wound or mucous membrane was contaminated by the animal’s saliva; the bite was unprovoked, the animal has not been vaccinated, The vaccination status of the suspect animal is questionable
- Immediate post exposure prophylaxis of all categorized exposures assessed as carrying a risk of developing rabies
- Extensive washing; flushing and local treatment of the bite wound or scratch as soon as possible after a suspected exposure; Administration of rabies vaccine, the administration of rabies immunoglobulin (RIG), if indicated, Relieve of any other symptoms such as pain with analgesics
- Monitor and manage any complications depending on the two forms of rabies – such as cardiopulmonary arrest as a result of furious rabies or muscle paralysis and coma due to paralytic rabies
- ICU services for patients with complications e.g. those in coma
- Integrated bite case management/alert the veterinary services to remove the biting animal from the community/quarantined
|
|
Condition: Yellow Fever
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical examination
- clinical diagnosis based on the patient's signs and symptoms, the travel history (when and where), the related travel activities and vaccine history
- Supportive treatment aimed at relieving symptoms including Relive pain and fever
- Monitoring and specific management of the disease depending on the severity including
- Oxygen administration - Intravenous fluid administration for dehydration
- Blood pressure control -medications to increase collection/blood_pressure in cases of circulatory collapse - transfusion of blood products in cases of severe bleeding
- Antibiotics for secondary bacterial_infections
- Management for any complication due to AEFI with yellow fever vaccine
-
- Tests- Blood tests to detect the virus in the early stages of the disease Or demonstrate the presence of virus-specific antibodies (IgM and IgG) in late stages of yellow fever.
|
|
< 5 years
|
|
|
- Physiacl examination
- clinical diagnosis based on the patient's signs and symptoms, the travel history (when and where), the related travel activities and vaccine history
- Supportive treatment aimed at relieving symptoms including Relive pain and fever
- Monitoring and specific management of the disease depending on the severity including
-
- Oxygen administration - Intravenous fluid administration for dehydration
-
- Blood pressure control -medications to increase collection/blood_pressure in cases of circulatory collapse - transfusion of blood products in cases of severe bleeding
-
- Antibiotics for secondary bacterial_infections
- Management for any complication due to AEFI with yellow fever vaccine
- Diagnostic Tests- Blood tests to detect the virus in the early stages of the disease Or demonstrate the presence of virus-specific antibodies (IgM and IgG) in late stages of yellow fever.
|
|
5 - 11 years
|
|
|
History and physical examination
Basic laboratory tests
Advanced laboratory tests
Supportive care (e.g. fever reduction, hydration, feeding, etc.)
IV fluid hydration
Treat mild complications
Refer if severe or not responding
|
|
12 - 24 years
|
|
|
- Physiacl examination
- clinical diagnosis based on the patient's signs and symptoms, the travel history (when and where), the related travel activities and vaccine history
- Supportive treatment aimed at relieving symptoms including Relive pain and fever
- Monitoring and specific management of the disease depending on the severity including
-
-
- Intravenous fluid administration for dehydration
-
- Blood pressure control -medications to increase collection/blood_pressure in cases of circulatory collapse
-
- transfusion of blood products in cases of severe bleeding
-
- Antibiotics for secondary bacterial_infections
-
-
- Management for any complication due to AEFI with yellow fever vaccine
- Diagnostic Tests- Blood tests to detect the virus in the early stages of the disease or demonstrate the presence of virus-specific antibodies (IgM and IgG) in late stages of yellow fever.
- Referral to specilsed hospital for further managemnent eg for dialysis ; ICU services as may be indicated
|
|
25 - 59 years
|
|
|
History and physical examination
Basic laboratory tests
Advanced laboratory tests
Supportive care (e.g., fever reduction, hydration, feeding, etc.)
IV fluid hydration
Treat mild complications
Refer if severe or not responding
|
|
60+ years
|
|
|
- Physiacl examination
- clinical diagnosis based on the patient's signs and symptoms, the travel history (when and where), the related travel activities and vaccine history
- Supportive treatment aimed at relieving symptoms including Relive pain and fever
- Monitoring and specific management of the disease depending on the severity including
-
-
- Intravenous fluid administration for dehydration
-
- Blood pressure control -medications to increase collection/blood_pressure in cases of circulatory collapse
-
- transfusion of blood products in cases of severe bleeding
-
- Antibiotics for secondary bacterial_infections
-
-
- Management for any complication due to AEFI with yellow fever vaccine
- Diagnostic Tests- Blood tests to detect the virus in the early stages of the disease or demonstrate the presence of virus-specific antibodies (IgM and IgG) in late stages of yellow fever.
- Referral to specialised hospital for further managemnent eg for dialysis ; ICU services as may be indicated
|
|
Condition: Acute Hepatitis C
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical
- Diagnosis of hepatitis C in pregnant women based on signs and symptoms
- Supportive therapies pregnant women with Hepatitis C including; - proper nutrition;
- fluids therapy - plenty of rest - relieve of pain
- Administration of Antiviral therapy
- Regular Monitoring for early diagnosis and management of any complications such as liver cirrhosis and liver cancer
- Nucleic acid test for HCV ribonucleic acid (RNA) to confirm chronic infection
- Regular Monitoring for early diagnosis and management of any complications such as liver cirrhosis and liver cancer
- Diagnostic tests
- Serological tests for anti-HCV antibodies (hepatitis C antibody test)
- Nucleic acid test for HCV ribonucleic acid (RNA) to confirm chronic infection
|
|
< 5 years
|
|
|
- Physical and clinical examination
- Diagnosis of hepatitis C in children based on signs and symptoms including fever, fatigue, decreased appetite, nausea, vomiting, abdominal pain, joint pain and yellowing of skin and the whites of the eyes
- Supportive therapies for children with Hepatitis C including - proper nutrition - fluids therapy - PLenty of rest - relieve of pain
- Monitor for any progression to Chronic Hepatitis C
- Follow up
- Deferring anti-retroviral treatment for children aged less than 12 years with chronic HCV infection until 12 years of age
|
|
5 - 11 years
|
|
|
- Physical and clinical examination
- Monitor for any progression to Chronic Hepatitis C
- Diagnosis of hepatitis C in children based on signs and symptoms including fever, fatigue, decreased appetite, nausea, vomiting, abdominal pain, joint pain and yellowing of skin and the whites of the eyes
- Supportive therapies for children with Hepatitis C including; - proper nutrition - fluids therapy - PLenty of rest - relieve of pain
- Monitor for any progression to Chronic Hepatitis C
- Follow up
- WHO -recommends Deferring anti-retroviral treatment for children aged less than 12 years with chronic HCV infection until 12 years of age
|
|
12 - 24 years
|
|
|
- Physical and clinical examination
- Diagnosis of hepatitis C in elderly based on signs and symptoms
- Supportive therapies to elderly with Hepatitis C including; - proper nutrition;
- fluids therapy - Adequate rest - relieve pain
- Administration of Antiviral therapy (use of pan-genotypic direct-acting antivirals (DAAs) for chronic HCV) after careful assessment
- Serological tests for anti-HCV antibodies (hepatitis C antibody test)
- Diagnostic tests
- Monitoring for progression to Chronic Hepatitis C
- Regular Monitoring for early diagnosis and management of any complications such as liver cirrhosis and liver cancer
- Nucleic acid test for HCV ribonucleic acid (RNA) to confirm chronic infection
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Physical and clinical examination,Diagnostic tests
- Diagnosis of hepatitis C in elderly based on signs and symptoms
- Supportive therapies to elderly with Hepatitis C including
- proper nutrition, fluids therapy,Adequate rest - relieve pain
- Serological tests for anti-HCV antibodies (hepatitis C antibody test)
- Monitoring for progression to Chronic Hepatitis C
- Administration of Antiviral therapy (use of pan-genotypic direct-acting antivirals (DAAs) for chronic HCV) after careful assessment
- Regular Monitoring for early diagnosis and management of any complications such as liver cirrhosis and liver cancer
- Nucleic acid test for HCV ribonucleic acid (RNA) to confirm chronic infection
|
|
Condition: Leprosy
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- physical and clinical examination
- Presumptive diagnosis of Leprosy based on cardinal signs;
- Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch
- Thickened or enlarged peripheral nerve with loss of sensation and/weakness of the muscles supplied by that nerve
- Guidance/Advice to elderly patients with leprosy on self-care including Care of Eyes, care of hands and feet, guidance on voluntary muscle testing and sensory testing use of correct footwear
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs, and eyes through early diagnosis and early treatment
- Follow up Guidance and Ensuring adherence to treatment for known leprosy patients
|
|
< 5 years
|
|
|
- physical and clinical examination
- Presumptive diagnosis of Leprosy based on cardinal signs:
- Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch *
- Thickened or enlarged peripheral nerve with loss of sensation and/or weakness of the muscles supplied by that nerve*
- Guidance to the elderly leprosy patient on adherence to treatment,
- Guidance /Advice to elderly patients with leprosy on self-care including Care of Eyes; care of hands and feet; guidance on voluntary muscle testing and sensory testing use of correct footwear
- Hospital admission
- Management of Leprosy with Multidrug therapy (MDT)
- Prevention and management of disabilities.
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs, and eyes through early diagnosis and early treatment
- Strengthening surveillance for antimicrobial resistance including laboratory network.
- Conducting basic and operational research in all aspects of leprosy and maximize the evidence base to inform policies, strategies and activities
|
|
5 - 11 years
|
|
|
- physical and clinical examination
- Presumptive diagnosis of Leprosy based on cardinal signs;
- Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch
- Thickened or enlarged peripheral nerve with loss of sensation and/weakness of the muscles supplied by that nerve
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs, and eyes through early diagnosis and early treatment
- Prevention and management of disabilities.
- Guidance/Advice to parents on care for the child with Leprosy including Care of Eyes, care of hands and feet, guidance on voluntary muscle testing and sensory testing use of correct footwear
- Referral to a hospital for definitive diagnosis and for further management
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs and eyes
- Guidance and Ensuring adherence to treatment for known leprosy patients
|
|
12 - 24 years
|
|
|
- physical and clinical examination
- Presumptive diagnosis of Leprosy based on cardinal signs:
- Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch *
- Thickened or enlarged peripheral nerve with loss of sensation and/or weakness of the muscles supplied by that nerve*
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs, and eyes through early diagnosis and early treatment
- Prevention and management of disabilities.
- Hospital admission
- Management of Leprosy with Multidrug therapy (MDT)
- Strengthening surveillance for antimicrobial resistance including laboratory network.
|
|
25 - 59 years
|
|
|
- physical and clinical examination
- Presumptive diagnosis of Leprosy based on cardinal signs;
- 1.Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch
- 2.Thickened or enlarged peripheral nerve with loss of sensation and/or weakness of the muscles supplied by that nerve
- Guidance to the elderly leprosy patient on adherence to treatment,
- Guidance/Advice to elderly patients with leprosy on self-care including Care of Eyes, care of hands and feet, guidance on voluntary muscle testing and sensory testing use of correct footwear
- Management of Leprosy with Multidrug therapy (MDT)
- Hospital admission
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs, and eyes through early diagnosis and early treatment
- Guidance and Ensuring adherence to treatment for known leprosy patients
|
|
60+ years
|
|
|
- physical and clinical examination
- Presumptive diagnosis of Leprosy based on cardinal signs;
- Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch,
- Thickened or enlarged peripheral nerve with loss of sensation and/or weakness of the muscles supplied by that nerve
- Guidance/Advice to elderly patients with leprosy on self-care including Care of Eyes,care of hands and feet, guidance on voluntary muscle testing and sensory testing use of correct footwear
- Definite loss of sensation in a pale (hypo pigmented) or reddish skin patch
- Thickened or enlarged peripheral nerve with loss of sensation and/or weakness of the muscles supplied by that nerve
- Follow up and prevention of complications including progressive and permanent damage to the skin, nerves, limbs, and eyes through early diagnosis and early treatment
- Prevention and management of disabilities.
- Management of Leprosy with Multidrug therapy (MDT)
- Hospital admission
- Follow up for patients
- Strengthening surveillance for antimicrobial resistance including laboratory network.
- Guidance and Ensuring adherence to treatment for known leprosy patients
|
|
Condition: Ascariasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Clinical diagnosis of ascariasis, history of passage of a live worm in faeces,abdominal pain while others may have cough, difficulty in breathing, or fever
- Supportive therapy including;
- Relieve of any abdominal pain with painkillers,
- Nutritional support (proper nutrition )
- Treatment using Anthelminthic medications such as albendazole and mebendazole
- Prevention and management of any complications due to ascariasis e.g breathing complications, surgical intervention for intraabdominal complications.
- Diagnostics
- Microscopy stool for identifying ascaris eggs
- Blood tests for eosinophilia
- Imaging for heavily invested individuals
- Ultrasound to detect hepatobiliary or pancreatic ascariasis
- Prevention and management of any complications due to ascariasis e.g breathing complications, surgical intervention for intraabdominal complications.
|
|
< 5 years
|
|
|
- Anthelmintic
- Steroids for complication
- Surgery for obstruction
|
|
5 - 11 years
|
|
|
- Anthelmintic
- Steroids for complication
- Surgery for obstruction
|
|
12 - 24 years
|
|
|
- Anthelmintic
- Steroids for complication
- Surgery for obstruction
|
|
25 - 59 years
|
|
|
- Anthelmintic
- Steroids for complication
- Surgery for obstruction
|
|
60+ years
|
|
|
- Anthelmintic
- Steroids for complication
- Surgery for obstruction
|
|
Condition: Tetanus
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Clinical diagnosis of tetanus based on Clinical features
- For neonatal tetanus–an illness occurring in an infant who has the normal ability to suck and cry in the first 2 days of life, but who loses this ability between days 3 and 28 of life and becomes rigid or has spasms
- Non-neonatal tetanus (in this case affecting the mothers)requires at least one of the following signs; a sustained spasm of the facial muscles in which the person appears to be grinning, or painful muscular contractions. And with a history of injury or wound, tetanus (but may also occur in patients who are unable to recall a specific wound or injury)
- Relieve of other symptoms such as headache with analgesics, fever with anti pyretic
- Immediate admission for mothers with tetanus/neonates with neonatal tetanus (Tetanus is a medical emergency)
- Administration of antibiotics
- Immediate management with medicines human tetanus immune globulin (TIG)
- Tetanus Vaccination for the mothers who have recovered since infection with tetanus does not confer natural immunity
- Prevention and management of any complications such as respiratory failure
- referral to specialised hospitals for further managemnet eg Intensive care services to mange severe tetanus/any complications eg for
|
|
< 5 years
|
|
|
** Physical and clinical examination
- Clinical diagnosis of tetanus based on Clinical features
- Non-neonatal tetanus requires at least one of the following signs: a sustained spasm of the facial muscles in which the person appears to be grinning or painful muscular contractions and with a history of injury or wound, tetanus (but may also occur in children whose parents/families are unable to recall a specific wound or injury)
- Relieve of other symptoms such as headache with analgesics, fever with anti pyretic
- Management/control of muscle spasms
- Administration of antibiotics
- Tetanus Vaccination for the under 5 since infection with tetanus does not confer natural immunity
- Prevention and management of any complications such as respiratory failure
- Referral to specialised Intensive care services to manage any complications/severe tetanus e.g for ventilation
- follow up
|
|
5 - 11 years
|
|
|
** Physical and clinical examination
- Clinical diagnosis of tetanus based on Clinical features
- Non-neonatal tetanus)requires at least one of the following signs: a sustained spasm of the facial muscles in which the person appears to be grinning or painful muscular contractions. And with a history of injury or wound, tetanus (but may also occur in patients who are unable to recall a specific wound or injury)*
- Relieve of other symptoms such as headache with analgesics, fever with anti pyretic
- Immediate admission for school age child with tetanus(Tetanus is a medical emergency)
- Immediate management with medicines human tetanus immune globulin (TIG)
- Prevention and management of any complications such as respiratory failure
- Referral to specialsed hospital for further managemnet eg Intensive care services to manage any complications/severe tetanus eg for ventilation
- Follow up
|
|
12 - 24 years
|
|
|
- Physical and clinical examination
- Clinical diagnosis of tetanus based on Clinical features
- Non-neonatal tetanus requires at least one of the following signs: a sustained spasm of the facial muscles in which the person appears to be grinning, or painful muscular contractions. And with a history of injury or wound, tetanus (but may also occur in adolescents who are unable to recall a specific wound or injury)**
- Supportive therapy-Relieve of other symptoms such as headache with analgesics, fever with anti-pyretic
- Immediate admission for adolescents with tetanus (Tetanus is a medical emergency)
- Immediate management with medicines human tetanus immune globulin (TIG)
- Prevention and management of any complications such as respiratory failure
-
- Aggressive wound care for the adolescents with tetanus
- Management/control of muscle spasms
- Administration of antibiotics
- Tetanus Vaccination for the adolescents who have recovered from tetanus since infection with tetanus does not confer natural immunity
- referral to specialised hosptals for further managemnet eg Intensive care services to manage any complications/severe tetanus eg for ventilation
- Follow up
|
|
25 - 59 years
|
|
|
- Physical and clinical examination
- Clinical diagnosis of tetanus based on Clinical features
- Non-neonatal tetanus requires at least one of the following signs: a sustained spasm of the facial muscles in which the person appears to be grinning or painful muscular contractions. And with a history of injury or wound, tetanus (but may also occur in adult patients who are unable to recall a specific wound or injury)*
- Supportive therapy-Relieve of other symptoms such as headache with analgesics fever with anti pyretic
- Immediate admission for adults with tetanus (Tetanus is a medical emergency)Immediate management with medicines human tetanus immune globulin (TIG)
- Aggressive wound care for the adults with tetanus
- Prevention and management of any complications
- Management/control of muscle spasms
- Administration of antibiotics
- Tetanus Vaccination for the adults who have recovered from tetanus since infection with tetanus does not confer natural immunity
- Referral to specialised hospitals for further managemnet eg Intensive care services to manage any complications/severe tetanus
- Follow up
|
|
60+ years
|
|
|
- Physical and clinical examination
- Clinical diagnosis of tetanus based on Clinical features
- Non-neonatal tetanus requires at least one of the following signs: a sustained spasm of the facial muscles in which the person appears to be grinning or painful muscular contractions and with a history of injury or wound, tetanus (but may also occur in elderly patients who are unable to recall a specific wound or injury)
- Supportive management-Relieve of other symptoms such as headache with analgesics fever with anti pyretic
- Immediate admission for the elderly person with tetanus(Tetanus is a medical emergency)
- Immediate management with medicines human tetanus immune globulin (TIG)
- Aggressive wound care for the elderly with tetanus
- Prevention and management of any complications such as respiratory failure
- Refferal to specialised hospitals for further managemnet eg Intensive care services to manage any complications/severe tetanus
- Follow up of elderly patients with tetanus
|
|
Condition: Trichuriasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Clinical diagnosis of Trichuriasis, history of passage of a live worm, in faeces, abdominal pain while others may have cough, difficulty in breathing or fever
- Supportive therapy including relieve of any abdominal pain with painkillers, nutritional support (proper nutrition)
- Treatment using Anthelminthic medications such as albendazole and mebendazole
- Diagnostic tests,
- Microscopy–stool for identifying trichuris eggs
- Endoscopy to see adult worms in GIT
- Prevention and management of any complications due to Trichuriasis e.g Viatmin A deficiency, anaemia, rectal prolapse
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Physical and clinical examination
- Clinical diagnosis of Trichuriasis, history of passage of a live worm, in faeces, abdominal pain while others may have cough, difficulty in breathing, or fever
Supportive therapy including relieve of any abdominal pain with painkillers; nutritional support (proper nutrition)
- Diagnostic tests
- Microscopy–stool for identifying trichuris eggs
- Endoscopy to see adult worms in GIT
- Clinical diagnosis of Trichuriasis, based on history of passage of a live worm in faeces, abdominal pain while others may have cough, difficulty in breathing or fever
- Treatment using Anthelminthic medications such as albendazole and mebendazole
- Prevention and management of complications e.g iron deficiency anaemia, rectal prolapse
|
|
25 - 59 years
|
|
|
- physical and clinical examination
- Clinical diagnosis of Trichuriasis, based on history of passage of a live worm in faeces, abdominal pain while others may have cough, difficulty in breathing or fever
- Supportive therapy including relieve of any abdominal pain with painkillers, nutritional support (proper nutrition)
- Diagnostic tests;
- Microscopy–stool for identifying trichuris eggs
- Endoscopy to see adult worms in GIT
- Treatment using Anthelminthic medications such as albendazole and mebendazole<
- Prevention and management of complications e.g Anaemia, rectal prolapse
|
|
60+ years
|
|
|
- Physical and clinical examination
- Clinical diagnosis of Trichuriasis, based on history of passage of a live worm in faeces abdominal pain while others may have cough, difficulty in breathing or fever
- Supportive therapy including relieve of any abdominal pain with painkillers, nutritional support (proper nutrition)
- Treatment using Anthelminthic medications such as albendazole and mebendazole
- Diagnostic tests - Microscopy–stool for identifying trichuris eggs - Endoscopy to see adult worms in GIT
- Prevention and management of complications e.g. anaemia, rectal prolapse
|
|
Condition: Birth asphyxia
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Start neonatal resuscitation for nenates with Apgar scores of 0 to 3 as follows;
- Dry neonate and place supine under overhead warmer
- Suctioning of airways Tactile stimulation to encourage spontaneous breathing Oxygen therapy,
- Bag-mask ventilation (Ambu bag) for non-responsive neonates Endotracheal intubation for neonates not responsive to bag-mask ventilation * * Chest compression if heart rate does not improve
- Transfer to neonatal intensive care unit for further assessment
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Birth trauma
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Clinical examination
- Physical examination
- Nutritional support
- antibitics terapy where indicated
- safe transportation of small babies
- Encourage KFC and /or KMC
- Refer to specialised hospitals for ICU services where indicated
- Laboratory services /invstigations that include but are not limited to:
- blood film microscopy,
- blood group and cross-match,
- blood chemistry, CSF and stool and urine microscopy, gram stain,
- Imaging modalities including
- x-ray
- ultra-sound
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Iodine deficiency
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Treat iodine deficiency cases with iodide with or without levothyroxine
- Plan for sugery for pregnant women with large goiters after delivery
|
|
< 5 years
|
|
|
- Treat iodine deficiency cases with iodide with or without levothyroxine
|
|
5 - 11 years
|
|
|
- Treat iodine deficiency cases with iodide with or without levothyroxine
|
|
12 - 24 years
|
|
|
- Treat iodine deficiency cases with iodide with or without levothyroxine
- Plan for surgery in cases with large goiters
|
|
25 - 59 years
|
|
|
- Treat iodine deficiency cases with iodide with or without levothyroxine
- Plan for surgery in cases with large goiters
|
|
60+ years
|
|
|
- Treat iodine deficiency cases with iodide with or without levothyroxine
- Plan for surgery in cases with large goiters
|
|
Condition: Maternal conditions
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Provide Comprehensive Emergency Obstetric Care services for women with obstetric complications
- Provide blood transfusion, Caesarean section and laparotomy services
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Neonatal sepsis and infections
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Antibiotics
- IV hydration
- Oxygen support
- Appropriate feeding including breast feeding
- Blood products transfusion
- Vasopressor agents
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Protein-energy malnutrition
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
- F-75 and F-100 therapeutic milks
- Ready-to-use therapeutic food (RUTF)
- Vitamin A supplementation
- Folic acid
- Deworming
- Antibiotics
- Measles vaccination
- Antimalarial
- Blood transfusion
- Manage hypothermia
- Manage hypoglycaemia
- Mange electrolyte imbalances
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Educate caregivers on feeding of the elderly through provision of practical examples using local foods
- Provide with multivitamin supplement
- Provide treatment to correct other specific deficiencies
- Refer severe cases of protein energy malnutrition to hospital for further management
- Treat mild to moderate cases with balanced oral diet
- Provide lactose free liquid oral food supplements if solid food cannot be adequately ingested
- Provide with multivitamin supplement
- Treat any underlying conditions
|
|
Condition: Preterm birth complications
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and Clinical examinations
- Assessment and follow up of preterm neonates for complications of prematurity
- Appropriate treatment of any detected complications of prematurity Intravenous or gavage feeding of preterm neonates born before 34 weeks
- Gradual transition of preterm neonates from intravenous or gavage feeding to breastfeeding
- Education of mothers on care of preterm neonates including Kangaroo Mother Care
- Use of Kangaroo Mother Care especially in hospitals without neonatal intensive care facilities and during period of observation before discharge
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Vitamin A deficiency
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
- Physical and clinical assessmnet
- Guidance to parents/families on feeding child with viatmin A rich foods eg eg, liver, beef, oily fish, chicken, eggs, fortified milk, carrots, mangoes, sweet potatoes and leafy green vegetables.
- Treat Vitamin A deficiency with Vitamin A supplemnts
- Treating underlying causes /conditions
- Follow up
|
|
5 - 11 years
|
|
|
- Vitamin A
- Vitamin A-rich foods
|
|
12 - 24 years
|
|
|
- Physical and clinical assessmnet
- Guidance to adolescents on eating viatmin A rich foods eg eg, liver, beef, oily fish, chicken, eggs, fortified milk, carrots, mangoes, sweet potatoes and leafy green vegetables.
- Treat Vitamin A deficiency with Vitamin A supplemnts
- Treating underlying causes /conditions
- Follow up
|
|
25 - 59 years
|
|
|
- Physical and clinical assessmnet
- Guidance to adults eating viatmin A rich foods eg eg, liver, beef, oily fish, chicken, eggs, fortified milk, carrots, mangoes, sweet potatoes and leafy green vegetables.
- Treat Vitamin A deficiency with Vitamin A supplemnts
- Treating underlying causes /conditions
- Follow up
|
|
60+ years
|
|
|
- Physical and clinical assessmnet
- Guidance to elderly on eating viatmin A rich foods eg eg, liver, beef, oily fish, chicken, eggs, fortified milk, carrots, mangoes, sweet potatoes and leafy green vegetables.
- Treat Vitamin A deficiency with Vitamin A supplemnts
- Treating underlying causes /conditions
- Follow up
|
|
Condition: Colon and rectum cancers
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Appropriate management of infections
- Early referral for additional procedures
|
|
60+ years
|
|
|
- Appropriate management of infections
- Early referral for additional procedures
|
|
Condition: Larynx cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Chemotherapy or radiation therapy
- Surgery for disease with extra-laryngeal extension
|
|
60+ years
|
|
|
- Chemotherapy or radiation therapy
- Surgery for disease with extra-laryngeal extension
|
|
Condition: Leukemia
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
- Immediate transfer of suspected cancer cases to a higher-level health care facility
|
|
5 - 11 years
|
|
|
- Immediate transfer of suspected cancer cases to a higher-level health care facility
|
|
12 - 24 years
|
|
|
- Immediate transfer of suspected cancer cases to a higher-level health care facility
|
|
25 - 59 years
|
|
|
- Assess people with anaemia or easy bruising and bleeding or recurrent infection where benign causes have been excluded for leukaemia
|
|
60+ years
|
|
|
- Assess people with anaemia or easy bruising and bleeding or recurrent infection where benign causes have been excluded for leukaemia
|
|
Condition: Liver Cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Appropriate management of infections
- Referral to the next level for diagnostic workup and treatment
|
|
Condition: Trachea, bronchus, lung cancers
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Appropriate management of infections
- Referral to the next level for diagnostic workup and treatment
|
|
60+ years
|
|
|
- Appropriate management of infections
- Referral to the next level for diagnostic workup and treatment
|
|
Condition: Malignant skin melanoma
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Surgical excision
- Adjuvant therapy after delivery
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Surgical excision Adjuvant radiation therapy
- Adjuvant interferon alfa
|
|
60+ years
|
|
|
- Surgical excision Adjuvant radiation therapy
- Adjuvant interferon alfa
|
|
Condition: Multiple myeloma
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Nasopharynx cancer and other pharyngeal cancers
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Chemotherapy and radiation therapy
|
|
60+ years
|
|
|
- Chemotherapy and radiation therapy
|
|
Condition: Oesophagus cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Surgery Chemotherapy
- Radiation
|
|
60+ years
|
|
|
- Appropriate management of infections
- Referral to the next level for diagnostic workup and treatment
|
|
Condition: Pancreas cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Radiation therapy
- Surgery Chemotherapy
|
|
60+ years
|
|
|
- Radiation therapy
- Surgery Chemotherapy
|
|
Condition: Non-melanoma skin cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Surgical excision
- Radiation therapy for metastatic cases
|
|
60+ years
|
|
|
- Surgical excision
- Radiation therapy for metastatic cases
|
|
Condition: Stomach cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Appropriate management of infections
- Referral to the next level for diagnostic workup and treatment
|
|
60+ years
|
|
|
- Appropriate management of infections
- Referral to the next level for diagnostic workup and treatment
|
|
Condition: Breast cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Institute Specialist teams to offer a combination of Surgery, Chemotherapy and Radiotherapy depending on the stage of the condition
- Ductal Carcinoma-In-Situ (DCIS) – Surgery and Radiotherapy
|
|
< 5 years
|
|
|
- Institute Specialist teams to offer a combination of Surgery, Chemotherapy and Radiotherapy depending on the stage of the condition
- Ductal Carcinoma-In-Situ (DCIS) – Surgery and Radiotherapy
|
|
5 - 11 years
|
|
|
- Institute Specialist teams to offer a combination of Surgery, Chemotherapy and Radiotherapy depending on the stage of the condition
- Ductal Carcinoma-In-Situ (DCIS) – Surgery and Radiotherapy
|
|
12 - 24 years
|
|
|
- Institute Specialist teams to offer a combination of Surgery, Chemotherapy and Radiotherapy depending on the stage of the condition
- Ductal Carcinoma-In-Situ (DCIS) – Surgery and Radiotherapy
|
|
25 - 59 years
|
|
|
- Immediate transfer of suspected cases to a higher-level health care facility
|
|
60+ years
|
|
|
- Immediate transfer of suspected cases to a higher-level health care facility
|
|
Condition: Cervix uteri cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
-
Physical and clinical examination
-
supportive managemnet including:
-
pain relieve
-
Nutritionla support
-
Admission where necessary
-
managemnet of opportunitsic infections
-
Management of any underlying conditions
-
Monitoring and managemnet of any complications
-
Blood transfusions
-
Oxygen therapy
-
Surgical interventions eg hysterectomy;further managemnet including managemnet of any complications
-
referral to specialised hospital for
-
Follow up invclidng counselling for compliance with treatmnent
-
INVESTIGATIONS /diagnostics
-
screening -PAP smear
-
colscopic examination
-
Blood tests
-
Other tests eg to check for metastasis
-
x-rays eg chest r-ray
-
CT scan
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Stages IA1 and IA2 – Surgery (Modified Radical Hysterectomy, Lymphadenectomy) and Brachytherapy
- Stages IB1, IB2, IIA1 – Open Radical Hysterectomy or Brachytherapy, External Pelvic Radiotherapy and Chemotherapy where surgery may not be indicated
- Stages IB3, IIA2, IIB, III, IVA – External Pelvic Radiation, Brachytherapy and Chemotherapy.
- Stage IVB and Recurrent Cancers – Chemotherapy
|
|
25 - 59 years
|
|
|
- History and physical examination for cervical cancer
- Cervical cancer screening using HPV-test or Visual inspection with acetic acid (VIA)
- Treatment of precancerous lesions with Cryotherapy and/or LEEP
- Early recognition of need for referral
|
|
60+ years
|
|
|
- Cryotherapy
- Loop electrosurgical excision procedure (LEEP)
- Intra-cavitary brachytherapy
|
|
Condition: Corpus uteri cancer
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Stage I – Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy)
- Stages II and III – Pelvic Radiation and Chemotherapy Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy) may also be done
- Stage IV – Surgery, Chemotherapy, Radiotherapy and Hormonal Therapy may be used in various combinations
|
|
< 5 years
|
|
|
- Stage I – Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy)
- Stages II and III – Pelvic Radiation and Chemotherapy Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy) may also be done
- Stage IV – Surgery, Chemotherapy, Radiotherapy and Hormonal Therapy may be used in various combinations
|
|
5 - 11 years
|
|
|
- Stage I – Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy)
- Stages II and III – Pelvic Radiation and Chemotherapy Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy) may also be done
- Stage IV – Surgery, Chemotherapy, Radiotherapy and Hormonal Therapy may be used in various combinations
|
|
12 - 24 years
|
|
|
- Stage I – Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy)
- Stages II and III – Pelvic Radiation and Chemotherapy Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy) may also be done
- Stage IV – Surgery, Chemotherapy, Radiotherapy and Hormonal Therapy may be used in various combinations
|
|
25 - 59 years
|
|
|
- Stage I – Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy)
- Stages II and III – Pelvic Radiation and Chemotherapy. Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy) may also be done
- Stage IV – Surgery, Chemotherapy, Radiotherapy and Hormonal Therapy may be used in various combinations
|
|
60+ years
|
|
|
- Stage I – Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy)
- Stages II and III – Pelvic Radiation and Chemotherapy Surgery (Total Hysterectomy with Bilateral Salpingo-OOphrectomy and Pelvic and Para-aortic lymphadenectomy) may also be done
- Stage IV – Surgery, Chemotherapy, Radiotherapy and Hormonal Therapy may be used in various combinations
|
|
Condition: Malaria
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Intravenous antimalarials for treatment of severe malaria
- IV Glucose
- IV anticonvulsants
- Blood and blood product transfusion
- Immediate transfer of unresponsive or complicated cases to a higher-level health care facility
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: African trypanosomiasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
-
- Physical and clinical examinaton
- *Experienced staff to conduct clinical assessment For T.b. gambiense **
- Treatment under direct observation either through outpatient or as inpatients
- Admission/inpatient services
- Treatmnet with relevant medication first-line treatment or second line treatmnet aas indicated
- Management of relapses
- Mananagement of nay complications eg reduce the risk of encephalopathy
- Management of any adverse drug effects- eg Encephalopathy gastrointestinal and skin reactions, pyrexia, and peripheral neuropathy.
- Diagnostic tests
- Microscopy of fresh blood chancre fluid or lymph node aspirate
- Microscopy of celebral spinal fluid (CSF) (wet preparation)
|
|
< 5 years
|
|
|
-
- Physical and clinical examinaton
- *Experienced staff to conduct clinical assessment For T.b. gambiense **
- Treatment under direct observation either through outpatient or as inpatients
- Admission/inpatient services
- Treatmnet with relevant medication first-line treatment or second line treatmnet aas indicated
- Management of relapses
- Mananagement of nay complications eg reduce the risk of encephalopathy
- Management of any adverse drug effects- eg Encephalopathy gastrointestinal and skin reactions, pyrexia, and peripheral neuropathy.
- Diagnostic tests
- Microscopy of fresh blood chancre fluid or lymph node aspirate
- Microscopy of celebral spinal fluid (CSF) (wet preparation)
|
|
5 - 11 years
|
|
|
-
- Physical and clinical examinaton
- *Experienced staff to conduct clinical assessment For T.b. gambiense **
- Treatment under direct observation either through outpatient or as inpatients
- Admission/inpatient services
- Treatmnet with relevant medication first-line treatment or second line treatmnet aas indicated
- Management of relapses
- Mananagement of nay complications eg reduce the risk of encephalopathy
- Management of any adverse drug effects- eg Encephalopathy gastrointestinal and skin reactions, pyrexia, and peripheral neuropathy.
- Diagnostic tests
- Microscopy of fresh blood chancre fluid or lymph node aspirate
- Microscopy of celebral spinal fluid (CSF) (wet preparation)
|
|
12 - 24 years
|
|
|
-
- Physical and clinical examinaton
- *Experienced staff to conduct clinical assessment For T.b. gambiense **
- Treatment under direct observation either through outpatient or as inpatients
- Admission/inpatient services
- Treatmnet with relevant medication first-line treatment or second line treatmnet aas indicated
- Management of relapses
- Mananagement of nay complications eg reduce the risk of encephalopathy
- Management of any adverse drug effects- eg Encephalopathy gastrointestinal and skin reactions, pyrexia, and peripheral neuropathy.
- Diagnostic tests
- Microscopy of fresh blood chancre fluid or lymph node aspirate
- Microscopy of celebral spinal fluid (CSF) (wet preparation)
|
|
25 - 59 years
|
|
|
-
- Physical and clinical examinaton
- *Experienced staff to conduct clinical assessment For T.b. gambiense **
- Treatment under direct observation either through outpatient or as inpatients
- Admission/inpatient services
- Treatmnet with relevant medication first-line treatment or second line treatmnet aas indicated
- Management of relapses
- Mananagement of nay complications eg reduce the risk of encephalopathy
- Management of any adverse drug effects- eg Encephalopathy gastrointestinal and skin reactions, pyrexia, and peripheral neuropathy.
- Diagnostic tests
- Microscopy of fresh blood chancre fluid or lymph node aspirate
- Microscopy of celebral spinal fluid (CSF) (wet preparation)
|
|
60+ years
|
|
|
-
- Physical and clinical examinaton
- *Experienced staff to conduct clinical assessment For T.b. gambiense **
- Treatment under direct observation either through outpatient or as inpatients
- Admission/inpatient services
- Treatmnet with relevant medication first-line treatment or second line treatmnet aas indicated
- Management of relapses
- Mananagement of nay complications eg reduce the risk of encephalopathy
- Management of any adverse drug effects- eg Encephalopathy gastrointestinal and skin reactions, pyrexia, and peripheral neuropathy.
- Diagnostic tests
- Microscopy of fresh blood chancre fluid or lymph node aspirate
- Microscopy of celebral spinal fluid (CSF) (wet preparation)
|
|
Condition: Schistosomiasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Echinococcosis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Cysticercosis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Anthelminthic therapy using albendazole (conventional dosage 15 mg/kg/day in 2 divided doses for 15 days) may be superior to praziquantel (50 mg/kg/day for 15 days) for the treatment of neurocysticercosis
- Co-administration of corticosteroids that cross the blood brain barrier (e.g. dexamethasone) is used to mitigate these effects
- Treatment of edema, intracranial hypertension or hydrocephalus, which may include ventricular shunt or other neurosurgical procedures
|
|
< 5 years
|
|
|
- Anthelminthic therapy using albendazole (conventional dosage 15 mg/kg/day in 2 divided doses for 15 days) may be superior to praziquantel (50 mg/kg/day for 15 days) for the treatment of neurocysticercosis
- Co-administration of corticosteroids that cross the blood brain barrier (e.g. dexamethasone) is used to mitigate these effects
- Treatment of edema, intracranial hypertension or hydrocephalus, which may include ventricular shunt or other neurosurgical procedures
|
|
5 - 11 years
|
|
|
- Anthelminthic therapy using albendazole (conventional dosage 15 mg/kg/day in 2 divided doses for 15 days) may be superior to praziquantel (50 mg/kg/day for 15 days) for the treatment of neurocysticercosis
- Co-administration of corticosteroids that cross the blood brain barrier (e.g. dexamethasone) is used to mitigate these effects
- Treatment of edema, intracranial hypertension or hydrocephalus, which may include ventricular shunt or other neurosurgical procedures
|
|
12 - 24 years
|
|
|
- Anthelminthic therapy using albendazole (conventional dosage 15 mg/kg/day in 2 divided doses for 15 days) may be superior to praziquantel (50 mg/kg/day for 15 days) for the treatment of neurocysticercosis
- Co-administration of corticosteroids that cross the blood brain barrier (e.g. dexamethasone) is used to mitigate these effects
- Treatment of edema, intracranial hypertension or hydrocephalus, which may include ventricular shunt or other neurosurgical procedures
|
|
25 - 59 years
|
|
|
- Anthelminthic therapy using albendazole (conventional dosage 15 mg/kg/day in 2 divided doses for 15 days) may be superior to praziquantel (50 mg/kg/day for 15 days) for the treatment of neurocysticercosis
- Co-administration of corticosteroids that cross the blood brain barrier (e.g. dexamethasone) is used to mitigate these effects
- Treatment of edema, intracranial hypertension or hydrocephalus, which may include ventricular shunt or other neurosurgical procedures.
|
|
60+ years
|
|
|
- Anthelminthic therapy using albendazole (conventional dosage 15 mg/kg/day in 2 divided doses for 15 days) may be superior to praziquantel (50 mg/kg/day for 15 days) for the treatment of neurocysticercosis
- Co-administration of corticosteroids that cross the blood brain barrier (e.g. dexamethasone) is used to mitigate these effects
- Treatment of edema, intracranial hypertension or hydrocephalus, which may include ventricular shunt or other neurosurgical procedures
|
|
Condition: Alzheimer disease and other dementias
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Cholinesterase inhibitors
- Psychosocial therapy
- Behavioural therapy
- Cognitive stimulation
|
|
Condition: Autism and Asperger syndrome
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
- Behaviour therapy
- Speech-language therapy
- Play-based therapy
- Physical therapy
- Occupational therapy
- Nutritional support
- Referral for specialized mental health and other needed services
|
|
5 - 11 years
|
|
|
- Behavioural therapy
- Symptomatic Pharmacotherapy
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Asthma
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- physical and clinical examination
- **Diagnostic tests including **
- Measure of lung function (Spirometry, Peak flow.)
- Methacholine challenge.
- Allergy testing. Either through a skin test or blood test
- Nitric oxide test to measure the amount of nitric oxide gas in the breath
- Sputum eosinophils
*Provocative testing for exercise and cold-induced asthma
*Imaging tests- chest x ray]
- Advice and guidance to the patient on recognition of asthma triggers and how to avoid them
- Use of medications -bronchodilator
- Quick-relief (rescue) medications for rapid, short-term symptom relief during an asthma attack. /inhalers
- Use Allergy medications
- Treatment of aggravating factors such as lower and upper respiratory tract infections
- Monitoring for and management of any complications
- Regular follow up
|
|
< 5 years
|
|
|
- Short-acting bronchodilator,
- Low-dose inhaled corticosteroid (ICS)
- Long-acting bronchodilator (LABA)
- Long-acting muscarinic agonist (LAMA)
- Supplemental oxygen
- Bilevel Positive Airway Pressure (BiPAP)
- Counselling on personalised asthma management plan
|
|
5 - 11 years
|
|
|
- Short-acting bronchodilator,
- Low-dose inhaled corticosteroid (ICS)
- Long-acting bronchodilator (LABA)
- Long-acting muscarinic agonist (LAMA)
- Supplemental oxygen
- Bilevel Positive Airway Pressure (BiPAP)
- Counselling on personalised asthma management plan
|
|
12 - 24 years
|
|
|
- Short-acting bronchodilator,
- Low-dose inhaled corticosteroid (ICS)
- Long-acting bronchodilator (LABA)
- Long-acting muscarinic agonist (LAMA)
- Supplemental oxygen
- Bilevel Positive Airway Pressure (BiPAP)
- Counselling on personalised asthma management plan
|
|
25 - 59 years
|
|
|
- Short-acting bronchodilator,
- Low-dose inhaled corticosteroid (ICS)
- Long-acting bronchodilator (LABA)
- Long-acting muscarinic agonist (LAMA)
- Oxygen supplementation
- Bilevel Positive Airway Pressure (BiPAP)
|
|
60+ years
|
|
|
- Short-acting bronchodilator,
- Low-dose inhaled corticosteroid (ICS)
- Long-acting bronchodilator (LABA)
- Long-acting muscarinic agonist (LAMA)
- Oxygen supplementation
- Bilevel Positive Airway Pressure (BiPAP)
|
|
Condition: Conduct disorder
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- Treat comorbid conditions such as attention-deficit/hyperactivity disorder
- Group parent training programme
- Parent and child training programmes
- Referral for specialized mental health and other needed services
|
|
12 - 24 years
|
|
|
- Treat comorbid conditions such as attention-deficit/hyperactivity disorder
- Group parent training programme
- Parent and child training programmes
- Referral for specialized mental health and other needed services
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Eating disorders
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Early detection and treatment of eating disorders
- Assessment mental and social well being
- Multi-disciplinary treatment approach involving psychiatrists, psychologists, physicians, dieticians or nutritional advisers, social workers,
- Diet education and advice/Nutrition counseling
- Medical nutrition therapy
- Advisory on exercises/exercise moderation /reducing excessive exercises
- Psychological interventions
- Cognitive behavioral therapy to help the patient control their thoughts
- Behavioral therapy focusing on assisting patient to gain control and change unwanted behaviors
- Medications
- Management of any concurrent mental ailments like depression and anxiety disorders.
- Monitoring: prevention and management of complications related to eating disorders in women such as infertility, threat of miscarriage
- Monitoring and management of other complications associated with eating disorders such as obesity, diabetes, hypertension (high blood pressure)
- Hospitalization for more serious cases.
- Follow up
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- Assessment of mental and social wellbeing of children with eating disorder
- multi-disciplinary treatment approach involving psychiatrists, psychologists, physicians, dieticians or nutritional advisers, social workers
- Medical nutrition therapy
- Psychological interventions
- Cognitive behavioural therapy
- Behavioural therapy
- Oral medications for eating disorders
- Management of any concurrent mental ailments like depression and anxiety disorders.
- Hospitalization for serious cases
- Referral
|
|
12 - 24 years
|
|
|
- Early detection and treatment of eating disorders
- Assessment mental and social well being
- Multi-disciplinary treatment approach involving psychiatrists, psychologists, physicians, dieticians or nutritional advisers, social workers,
- Diet education and advice/Nutrition counseling
- Medical nutrition therapy
- Advisory on exercises/exercise moderation/reducing excessive exercises
- Psychological interventions
- Cognitive behavioral therapy to help the patient control their thoughts
- Behavioral therapy focusing on assisting patient to gain control and change unwanted behaviors
- Medications
- Management of concurrent mental ailments like depression anxiety disorders and substance abuse
- Monitoring and management of any complications associated with eating disorders such as obesity, diabetes,
- Hospitalization for more serious cases.
- Follow up
|
|
25 - 59 years
|
|
|
- Early detection and treatment of eating disorders
- Assessment mental and social well being
- Multi-disciplinary treatment approach involving psychiatrists, psychologists, physicians, dieticians or nutritional advisers, social workers,
- Diet education and advice/Nutrition counseling
- Medical nutrition therapy
- Advisory on exercises/exercise moderation/reducing excessive exercises
- Psychological interventions
- Cognitive behavioral therapy to help the patient control their thoughts
- Behavioral therapy focusing on assisting patient to gain control and change unwanted behaviors
- Medications
- Management of concurrent mental ailments like depression and anxiety disorders.
- Monitoring and management of any complications associated with eating disorders such as obesity, diabetes, hypertension (high blood pressure) and heart disease.
- Hospitalization for more serious cases.
- Follow up
|
|
60+ years
|
|
|
- Early detection and treatment of eating disorders
- Assessment mental and social well being
- Multi-disciplinary treatment approach involving psychiatrists, psychologists, physicians, dieticians or nutritional advisers, social workers,
- Diet education and advice /Nutrition counseling
- Medical nutrition therapy
- Advisory on exercises/exercise moderation /reducing excessive exercises
- Psychological interventions
- Cognitive behavioral therapy to help the patient control their thoughts
- Behavioral therapy focusing on assisting patient to gain control and change unwanted behaviors
- Medications
- Management of concurrent mental ailments like depression and anxiety disorders.
- Monitoring and management of any complications associated with eating disorders such as obesity, diabetes, hypertension (high blood pressure) and heart disease.
- Hospitalization for more serious cases.
- Follow up
|
|
Condition: COVID-19
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
-
Physical examination
-
Perform triage and clinical assessment,Check vital signs,temperature, respiratory rate,pulse, blood pressure, mental status (AVPU) and pulse oximetry.
-
Supportive treatment aimed at relieving symptoms including Relive pain and fever
-
Monitoring and specific management of the disease depending on the severity
-
Management of airways for patient with severe disease
-
Oxygen therapy for patient with severe disease
-
Medication for patient with severe or critical covid-19 including administration of corticosteroids,anti coagulants
-
Blood pressure control
-
Blood sugar monitoring and control
-
Antibiotics for any secondary bacterial infections
-
Management for any complication due to AEFI
-
Referral to a specialised hospital for ICU services for endotracheal intubation and mechanical ventilation in cases of respiratory complications
-
Follow up
-
Diagnostics /investigations
-
Polymerase Chain reaction test (PCR test) for COVID
-
Blood test
-
Chest Xrays
-
Ultra-sound
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Periodontal disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical, clinical and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every tooth
- Diagnostics including;
* Study models for diagnostics especially of gingival recession
* Use of clinical photographs calibrated by inclusion of a probe to monitor gingival recession
* Use of Radiographs (x-rays) to determine the extent of periodontal disease and for treatment planning. These include periapical radiographs & or panoramic radiographs
- Treatment planning and Patient education on the treatment choice
- Oral Hygiene instructions modelled on patient behaviour change strategies (TIPPS-talk, instruct, practice, plan, support)
- Use of mouth washes as a temporary primary oral hygiene measure
- Removal of plaque and calculus including supragingival debridement and root surface instrumentation
- Ensure that the patient is motivated to achieve and maintain effective plaque removal.
- Management of Local Plaque-retentive Factors e.g. crowded teeth, partial dentures, bridgework, orthodontic appliances
- Antimicrobial Medication; Local antimicrobials, including disinfectants such as chlorhexidine and systemic antimicrobials
- Use of analgesics where there is pain
- Advanced treatment through periodontal surgery to prevent more bone loss
- Management of any underlying conditions such as diabetes/cardiovascular disease that predisposes to periodontal disease
- Supportive periodontal therapy-long term program of Follow up and check ups after successful periodontal treatment
|
|
< 5 years
|
|
|
- Physical, clinical and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every tooth
- Diagnostics including;
* Study models for diagnostics especially of gingival recession
* Use of clinical photographs calibrated by inclusion of a probe to monitor gingival recession
* Use of Radiographs (x-rays) to determine the extent of periodontal disease and for treatment planning. These include periapical radiographs & or panoramic radiographs
- Oral Hygiene instructions modelled on patient behaviour change strategies (TIPPS-talk, instruct, practice, plan, support)
- Use of mouth washes as a temporary primary oral hygiene measure
- Removal of plaque and calculus including supragingival debridement and root surface instrumentation
- Ensure that the patient is motivated to achieve and maintain effective plaque removal.
- Management of Local Plaque-retentive Factors e.g. crowded teeth, partial dentures, bridgework, orthodontic appliances
- Antimicrobial Medication; Local antimicrobials, including disinfectants such as chlorhexidine and systemic antimicrobials
- Use of analgesics where there is pain
- Supportive periodontal therapy-long term program of Follow up and check ups after successful periodontal treatment
|
|
5 - 11 years
|
|
|
- Physical, clinical and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every tooth
- Diagnostics including;
* Study models for diagnostics especially of gingival recession
* Use of clinical photographs calibrated by inclusion of a probe to monitor gingival recession
* Use of Radiographs (x-rays) to determine the extent of periodontal disease and for treatment planning. These include periapical radiographs or panoramic radiographs
- Treatment planning and school age child education on the treatment choice
- Oral Hygiene instructions modelled on patient behaviour change strategies (TIPPS-talk, instruct, practice, plan, support)
- Use of mouth washes as a temporary primary oral hygiene measure
- Removal of plaque and calculus including supragingival debridement and root surface instrumentation
- Ensure that the patient is motivated to achieve and maintain effective plaque removal.
- Management of Local Plaque-retentive Factors e.g. crowded teeth, partial dentures, bridgework, orthodontic appliances
- Antimicrobial Medication; Local antimicrobials, including disinfectants such as chlorhexidine and systemic antimicrobials
- Use of analgesics where there is pain
- Advanced treatment through periodontal surgery to prevent more bone loss
- Management of any underlying conditions in school age child such as diabetes /cardiovascular disease that predisposes to periodontal disease
- Supportive periodontal therapy-long term program of Follow up and check ups after successful periodontal treatment
|
|
12 - 24 years
|
|
|
- Physical, clinical and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every tooth
- Diagnostics including;
* Study models for diagnostics especially of gingival recession
* Use of clinical photographs calibrated by inclusion of a probe to monitor gingival recession
* Use of Radiographs (x-rays) to determine the extent of periodontal disease and for treatment planning. These include periapical radiographs & or panoramic radiographs
- Treatment planning and Patient education on the treatment choice
- Oral Hygiene instructions modelled on patient behaviour change strategies (TIPPS-talk, instruct, practice, plan, support)
- Use of mouth washes as a temporary primary oral hygiene measure
- Removal of plaque and calculus including supragingival debridement and root surface instrumentation
- Ensure that the patient is motivated to achieve and maintain effective plaque removal.
- Management of Local Plaque-retentive Factors e.g. crowded teeth, partial dentures, bridgework, orthodontic appliances
- Antimicrobial Medication, Local antimicrobials, including disinfectants such as chlorhexidine and systemic antimicrobials
- Use of analgesics where there is pain
- Advanced treatment through periodontal surgery to prevent more bone loss
- Management of any underlying conditions such as diabetes /cardiovascular disease that predisposes to periodontal disease
- Supportive periodontal therapy-long term program of Follow up and check-ups after successful periodontal treatment
|
|
25 - 59 years
|
|
|
- Physical, clinical and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every tooth
- Diagnostics including;
- Study models for diagnostics especially of gingival recession
- Use of clinical photographs calibrated by inclusion of a probe to monitor gingival recession
- Use of Radiographs (x-rays) to determine the extent of periodontal disease and for treatment planning. These include periapical radiographs & or panoramic radiographs
- Treatment planning and Patient education on the treatment choice
- Oral Hygiene instructions modelled on patient behaviour change strategies (TIPPS-talk, instruct, practice, plan, support)
- Use of mouth washes as a temporary primary oral hygiene measure
- Removal of plaque and calculus including supragingival debridement and root surface instrumentation
- Ensure that the patient is motivated to achieve and maintain effective plaque removal.
- Management of Local Plaque-retentive Factors e.g. crowded teeth, partial dentures, bridgework, orthodontic appliances
- Antimicrobial Medication; Local antimicrobials, including disinfectants such as chlorhexidine and systemic antimicrobials
- Use of analgesics where History and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every there is pain
- Advanced treatment through periodontal surgery to prevent more bone loss
- Management of any underlying conditions such as diabetes /cardiovascular disease that predisposes to periodontal disease
- Supportive periodontal therapy-long term program of Follow up and check ups after successful periodontal treatment
|
|
60+ years
|
|
|
- Physical, clinical and full periodontal assessment involving charting of recession, probing depths, bleeding on probing and mobility for every tooth
- Diagnostics including:
- Study models for diagnostics especially of gingival recession
- Use of clinical photographs calibrated by inclusion of a probe to monitor gingival recession
- Use of Radiographs (x-rays) to determine the extent of periodontal disease and for treatment planning. These include periapical radiographs & or panoramic radiographs
- Treatment planning and Patient education on the treatment choice
- Oral Hygiene instructions modelled on patient behaviour change strategies (TIPPS-talk, instruct, practice, plan, support)
- Use of mouth washes as a temporary primary oral hygiene measure
- Removal of plaque and calculus including supragingival debridement and root surface instrumentation
- Ensure that the patient is motivated to achieve and maintain effective plaque removal.
- Management of Local Plaque-retentive Factors e.g.crowded teeth, partial dentures, bridgework, orthodontic appliances
- Antimicrobial Medication, Local antimicrobials, including disinfectants such as chlorhexidine and systemic antimicrobials
- Use of analgesics where there is pain
- Advanced treatment through periodontal surgery to prevent more bone loss
- Management of any underlying conditions such as diabetes /cardiovascular disease that predisposes to periodontal disease
- Supportive periodontal therapy-long term program of Follow up and check ups after successful periodontal treatment
|
|
Condition: Trachoma
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Physical and clinical examination
- _ Medication --Chemotherapy with Azithromycin (AZM)
- Trichiasis surgery for trachoma
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Onchocerciasis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Oral ivermectin
- Manage Mazzotti reaction
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Eye Conditions
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
-
Admission when necessary
-
Follow up
-
Antibiotics treatment for eye infections
-
Provide specialized medical and surgical eye interventions
-
High care Vision impairment assessments
-
Management of any underlying conditions such as diabetes, hypertension
-
Screen for refractory errors & provide eye glasses
-
surgical treatment for eye conditions
- Clinical and physical examination
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Otitis media
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Attention deficit/hyperactivity syndrome
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
-
- physical and clinical examination
- Symptomatic diagnosis of AHDD-Inattention, hyperactivity, disruptive behavior and impulsivity
-
- Diagnosis based on assessment of child’s behavioral and mental development (must have been diagnosed by the age of six)
- Psychotherapy and Psychosocial Interventions including;
- Behavioral therapy to help the patient change their behavior
- Cognitive behavioral therapy to teach on mindfulness techniques or meditation and help patient adjust to the life changes that come with treatment,
- Medication therapy (e.g. use of non-stimulants & stimulants) to reduce hyperactivity and impulsivity and improve ability to focus, work, learn and physical coordination
- Monitoring and management of complications including those related to medication use including headaches; increased anxiety and irritability
- Rule out effects of drugs, medications and other medical or psychiatric problems as the cause of ADHD
- Follow up
|
|
5 - 11 years
|
|
|
- physical and clinical examination
- Symptomatic diagnosis of AHDD-Inattention, hyperactivity, disruptive behavior and impulsivity
-
- Diagnosis based on assessment of child’s behavioral and mental development (must have been diagnosed by the age of six)
- Psychotherapy and Psychosocial Interventions including;
- Behavioral therapy to help the patient change their behavior
- Cognitive behavioral therapy to teach on mindfulness techniques or meditation and help patient adjust to the life changes that come with treatment,
- Medication therapy (e.g. use of non-stimulants & stimulants) to reduce hyperactivity and impulsivity and improve ability to focus, work, learn and physical coordination.
- Monitoring and management of complications including those related to medication use including headaches; increased anxiety and irritability
- Rule out effects of drugs, medications and other medical or psychiatric problems as the cause of ADHD
- Follow up
|
|
12 - 24 years
|
|
|
- physical and clinical examination
- Symptomatic diagnosis of AHDD-Inattention, hyperactivity, disruptive behavior and impulsivity
-
- Diagnosis based on assessment of child’s behavioral and mental development (must have been diagnosed by the age of six)
- Psychotherapy and Psychosocial Interventions including;
- Behavioral therapy to help the patient change their behavior
- Cognitive behavioral therapy to teach on mindfulness techniques or meditation and help patient adjust to the life changes that come with treatment.
- Medication therapy (e.g. use of non-stimulants & stimulants) to reduce hyperactivity and impulsivity and improve ability to focus, work, learn and physical coordination.
- Monitoring and management of complications including those related to medication use including headaches; increased anxiety and irritability
- Rule out effects of drugs, medications and other medical or psychiatric problems as the cause of ADHD
- Follow up
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Epilepsy
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Migraine
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- History, and physical and neurologic examination to help make a diagnosis
- Non-pharmacological (Non -drug) measures /management of migraine in pregnant women including ;
- Hydration
- regular meals
- advice on Reduction of caffeine intake
- Sleep hygiene —(Avoid bright lights, enough sleep)
- Regular exercise
- Relaxation therapy,
- Pharmacological/drug management of migraine in pregnant women with first line analgesisc such as;
- paracetamol
- use of anti-emetics if there is history of vomiting
- Migraine prophylaxis
- Blood pressure monitoring
- Monitor and manage any secondary causes of headaches in pregnant women such as pre-eclampsia and cerebral venous thrombosis, sub arachnoid haemorrhage, space occupying lesions
- Provide alternatives to Hormonal contraception for women who may experience onset or aggravation of migraine after starting them.
- Follow up and support to patients to ensure optimum treatment is achieved
|
|
< 5 years
|
|
|
- Physical and neurologic examination to help in the diagnosis
- Identification of features of migraine in children including shorter-lasting headaches attacks, commonly bilateral and less usually pulsating headache, gastrointestinal disturbance
- Use of drug therapy -analgesics (ibuprofen) in children with migraine, anti-emetics when vomiting is present
- Use of non-drug treatment (non- pharmacologic therapy for migraine in children through bed rest, relaxation therapy, physiotherapy
- Management of any underlying conditions that may be causing migraine in under 5 e.g. . cancer, space occupying lesions
- Monitor for any features of migraine headaches due to underlying conditions such as; headache projectile vomiting that may be due to intracranial space-occupying lesion, new headache in a patient with a history of cancer, HIV infection or immunodeficiency
- Follow up to ensure optimum treatment is achieved
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Nonsteroidal anti-inflammatory drugs
- Triptans
- Dopamine antagonist
- Antiemetic
- Non-pharmacologic therapy: lifestyle changes to reduce stress and improve relaxation
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
|
|
Condition: Edentulism
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Physical and clinical examination
- Complete dentures as replacement of teeth in edentulous elderly i.e.
- Complete Removable acrylic dentures
- Digitally fabricated complete dentures
- Tooth retained over denture
- Dental implants/implant supported prosthesis for edentulous elderly patients
- Management of any conditions due to use of dentures such as mucosal changes: traumatic ulcers, denture stomatitis, candida infection, angular chelitis and soft tissue hyperplasia.
- Management of other cormobidities associated with being edentulous includng poor dietray habits and nutritional intake; increased risk of hypertension and coronary artery disease.
- Nutritional support including vitamins supplementation
- Patient education on use of the dentures
- Radigraphc examination --Orthopantomography (OPG)
- Recall and Follow up
|
|
Condition: Parkinson disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Medical history and neurological examination
- Diagnosis through neuro-imaging -MRI
- Symptomatic treatment
- Diet therapy/guidance on balanced diet
- Use of medication such as levodopa
- Surgery for deep brain stimulation has been used to reduce motor symptoms in severe cases where drugs are ineffective.
- Monitoring the disease progression and management of any complications arising
- Management of difficulties in swallowing/feeding e.g., through use of feeding tube
- Managing breathing complications e.g., through use of non-invasive ventilator, and tracheostomy.
- Management of Urine incontinence
- Management of constipation, pain, blood pressure
- Management of secondary causes of parkinsonism’s such as stroke
|
|
60+ years
|
|
|
- Dopaminergic medications
- Non-dopaminergic medications
|
|
Condition: Hookworm disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Diagnosis based of the different clinical entities of hookworm disease i.e. Classic hookworm disease (gastrointestinal (GI) infection), Cutaneous larva migrans and Eosinophilic enteritis -
- Nutrition support/therapy to address any deficiency of nutrients due to the worms (e.g. Iron, Protein)
- Administration of anthelminthic drugs (e.g. mebendazole, albendazole) to pregnant women with hook worm disease
- Management of larvae in the skin (Topical administration of anthelminthic e.g. .Thiabendazole to destroy the larvae in the skin.
- Local cryotherapy to destroy the hookworms while still in the skin,
- Management of anemia and its complications (use of iron supplements, vitamin C. Folic acid and vitamin B12 supplements)
Diagnostic tests
- Examination of a stool sample to identify hookworm eggs
- Blood tests to check for anemia and nutritional deficiencies
- Chest X-ray to check lung involvement in hookworm infection.
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- Anthelmintic
- Iron supplementation
- Blood transfusion
|
|
12 - 24 years
|
|
|
- Nutritional support/therapy to address any deficiency of nutrients due to the worms (e.g. Iron,Protein)
- Administration of anthelminthic drugs (e.g. mebendazole; albendazole) to adolescents with hook worm disease
- Management of larvae in the skin (Topical administration of anthelminthic e.g. .Thiabendazole to destroy the larvae in the skin.
- Local cryotherapy to destroy the hookworms while still in the skin,
- Management of anemia and its complications (use of iron supplements, vitamin C. Folic acid and vitamin B12 supplements)
Diagnostic tests
- Examination of a stool sample to identify hookworm eggs
- Blood tests to check for anemia and nutritional deficiencies
- Chest X-ray to check lung involvement in hookworm infection.
|
|
25 - 59 years
|
|
|
- Nutrition support/therapy to address any deficiency of nutrients due to the worms (e.g. Iron, Protein)
- Administration of anthelminthic drugs (e.g. mebendazole; albendazole) to adults with hook worm disease
- Management of larvae in the skin (Topical administration of anthelminthic e.g. .Thiabendazole to destroy the larvae in the skin.
- Local cryotherapy to destroy the hookworms while still in the skin
- Management of anemia and its complications (use of iron supplements, vitamin C. Folic acid and vitamin B12 supplements)
Diagnostic tests
- Examination of a stool sample to identify hookworm eggs
- Blood tests to check for anemia and nutritional deficiencies
- Chest X-ray to check lung involvement in hookworm infection.
|
|
60+ years
|
|
|
- Diagnosis based of the different clinical entities of hookworm disease i.e. Classic hookworm disease (gastrointestinal (GI) infection), Cutaneous larva migrans and Eosinophilic enteritis
- Nutrition support/therapy to address any deficiency of nutrients due to the worms (e.g. Iron, Protein)
- Administration of anthelminthic drugs (e.g. mebendazole; albendazole) to elderly persons with hook worm disease
- Management of larvae in the skin ( Topical administration of anthelminthic e.g. .Thiabendazole to destroy the larvae in the skin.
- Local cryotherapy to destroy the hookworms while still in the skin
- Management of anemia and its complications (use of iron supplements, vitamin C. Folic acid and vitamin B12 supplements)
Diagnostic tests
- Examination of a stool sample to identify hookworm eggs
- Blood tests to check for anemia and nutritional deficiencies
- Chest X-ray to check lung involvement in hookworm infection.
|
|
Condition: Lower respiratory tract infections (LRTI)
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Parenteral antibiotics
- Oxygen supplementation
- IV fluids
|
|
< 5 years
|
|
|
- Parenteral antibiotics
- Oxygen supplementation
- IV fluids
|
|
5 - 11 years
|
|
|
- Parenteral antibiotics
- Oxygen therapy
- IV fluids
|
|
12 - 24 years
|
|
|
- IV/IM antibiotics
- Oxygen supplementation
- IV fluids
- Oxygen therapy
- IV fluids
|
|
25 - 59 years
|
|
|
- IV/IM antibiotics
- Oxygen supplementation
- IV fluids
|
|
60+ years
|
|
|
- Antibiotics
- Oxygen supplementation
- IV fluids
|
|
Condition: Non-migraine headache
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
- Identify and distinguish the different types of non-migraine headaches based the clinical features including;
- For tensional headache, usually mild or moderate, more generalized and typically described as pressure or tightness
- For cluster headache, severe headache strictly unilateral around the eye red and watering eyes with running or blocked nostrils and marked agitation
- Medication over use headache-usually due to chronic use of medication mainly for migraine or tension headache (usually diagnosed if symptoms improve within 2 months of medicine withdrawal)
- Encourage patient to keep a headache diary to study the patterns of the headache and associated symptoms
- Medication -use of analgesics such as ibuprofen
- Guidance to patient on relaxation techniques including;
- Heat therapy, such as applying warm compresses or taking a warm shower
- Massage
- Meditation
- Neck stretching
- Relaxation exercises
- Identify warning features of serious headaches or headaches due to underlying conditions such as new headache in a patient with cancer, HIV, headache with motor weakness could indicate stroke,
- Management of any underlying conditions causing headaches
- Patients follow up
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
- Physicaland clinical examination
- Identify and distinguish the different types of non-migraine headaches based the clinical features including;
- For tensional headache, usually mild or moderate; more generalized and typically described as pressure or tightness
- For cluster headache, severe headache strictly unilateral around the eye, red and watering eyes with running or blocked nostrils and marked agitation
- Medication over use headache -usually due to chronic use of medication mainly for migraine or tension headache (usually diagnosed if symptoms improve within 2 months of medicine withdrawal)
- Encourage patient to keep a headache diary to study the patterns of the headache and associated symptoms
- Medication -use of analgesics such as ibuprofen
- Guidance to patient on relaxation techniques including;
- Heat therapy, such as applying warm compresses or taking a warm shower
- Massage
- Meditation
- Neck stretching
- Relaxation exercises
- Identify warning features of serious headaches or headaches due to underlying conditions such as new headache in a patient with cancer,HIV, headache with motor weakness could indicate stroke,
- Management of any underlying conditions causing headaches
- Patients follow up
|
|
12 - 24 years
|
|
|
- Physical and clinical examination
- Identify and distinguish the different types of non-migraine headaches based the clinical features including;
- For tensional headache, usually mild or moderate, more generalized and typically described as pressure or tightness
- For cluster headache; severe headache strictly unilateral around the eye; red and watering eyes with running or blocked nostrils and marked agitation
- Medication over use headache -usually due to chronic use of medication mainly for migraine or tension headache (usually diagnosed if symptoms improve within 2 months of medicine withdrawal)
- Encourage patient to keep a headache diary to study the patterns of the headache and associated symptoms
- Medication-use of analgesics such as ibuprofen
- Guidance to patient on relaxation techniques including;
- heat therapy, such as applying warm compresses or taking a warm shower
- Massage
- Meditation
- Neck stretching
- Relaxation exercises
- Identify warning features of serious headaches or headaches due to underlying conditions such as new headache in a patient with cancer, HIV, headache with motor weakness could indicate stroke,
- Management of any underlying conditions causing headaches
- Patients follow up
|
|
25 - 59 years
|
|
|
- Physical and clinical examination
- Identify and distinguish the different types of non-migraine headaches based the clinical features including;
- For tensional headache, usually mild or moderate, more generalized and typically described as pressure or tightness
- For cluster headache, severe headache strictly unilateral around the eye, red and watering eyes with running or blocked nostrils and marked agitation
- Medication over use headache-usually due to chronic use of medication mainly for migraine or tension headache (usually diagnosed if symptoms improve within 2 months of medicine withdrawal)
- Encourage patient to keep a headache diary to study the patterns of the headache and associated symptoms
- Medication -use of analgesics such as ibuprofen
- Guidance to patient on relaxation techniques including;
- heat therapy, such as applying warm compresses or taking a warm shower
- Massage
- Meditation
- Neck stretching
- Relaxation exercises
- Identify warning features of serious headaches or headaches due to underlying conditions such as new headache in a patient with cancer, HIV, headache with motor weakness could indicate stroke,
- Management of any underlying conditions causing headaches
- Patients follow up
|
|
60+ years
|
|
|
- Physical and clinical examination
- Identify and distinguish the different types of non-migraine headaches based the clinical features including;
- For tensional headache, usually mild or moderate, more generalized and typically described as pressure or tightness
- For cluster headache, severe headache strictly unilateral around the eye, red and watering eyes with running or blocked nostrils and marked agitation
- Medication over use headache-usually due to chronic use of medication mainly for migraine or tension headache (usually diagnosed if symptoms improve within 2 months of medicine withdrawal)
- Encourage patient to keep a headache diary to study the patterns of the headache and associated symptoms
- Medication-use of analgesics such as ibuprofen
- Guidance to patient on relaxation techniques including;
- Heat therapy, such as applying warm compresses or taking a warm shower
- Massage
- Meditation
- Neck stretching
- Relaxation exercises
- Identify warning features of serious headaches or headaches due to underlying conditions such as new headache in a patient with cancer, HIV, headache with motor weakness could indicate stroke,
- Management of any underlying
|
|
Condition: Ischaemic (Coronary) Heart Disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Thrombolytic drugs
- Oxygen supplementation and ventilation support
- Antiplatelet drugs (e.g. Aspirin)
- Angiotensin-converting enzyme (ACE) inhibitors
- Lipid lowering medications (statins)
- Beta blockers,
- Calcium channel blockers
- Therapeutic lifestyle modification
- Stabilization and referral of acute complications
|
|
60+ years
|
|
|
- Thrombolytic drugs
- Oxygen supplementation and ventilation support
- Antiplatelet drugs (e.g. Aspirin)
- Angiotensin-converting enzyme (ACE) inhibitors
- Lipid lowering medications (statins)
- Beta blockers,
- Calcium channel blockers
- Therapeutic lifestyle modification
- Stabilization and referral of acute complications
|
|
Condition: Haemorrhagic Stroke
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Immediate emergency treatment for elderly persons with hemorrhagic stroke.
- Controlling the bleeding in the brain
- Reducing the pressure caused by the bleeding.
- Supportive care
- Fluids therapy-IV fluids
- Plenty of rest rest
- Surgical interventions for serious haemorrhagic stroke-e.g. to repair raptured vessels
- Management of other associated medical problems e.g. blood pressure
- ICU services
- Follow up
|
|
Condition: Ischaemic Stroke
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- ABC (Airway, breathing, and circulatory) support
- Thrombolytic medications
- Antihypertensive medication
- Glycaemia control
- Temperature control
- DVT Prophylaxis
- Anti-seizure medications
- Antiplatelet treatment (e.g. ASA)
- Lipid lowering medications
|
|
Condition: Peptic Ulcers
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Physical and clinical examination
-
- Diagnostic tests including; **
- Blood tests for antibodies due to H.pylori
- Stool for signs of the bacteria
- Urea breath test
- Advice on Cessation of tobacco smoking
- Advice/guidance on Stoppage of alcohol
- Stoppage of use of NSAIDs for ulcers caused by taking NSAIDs
- Fluids therapy
- Combination therapy to eradicate H.Pylori bacteria
- Medication to decrease stomach acidity - proton pump inhibitor (PPI) or an H2 blocker
- Follow up, prevention and management of Peptic ulcer complications including Gastrointestinal bleeding; Perforation, peritonitis.Cancer
- Management of anemia due to bleeding complication
- Blood transfusion if ulcers bleeding is severe
- Follow up
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Physical and clinical examination
- Diagnostic tests including;
- Endoscopy
- X-rays/barium swallow.
- Blood tests for antibodies due to H.pylori
- Urea breath test,
- Stool for signs of the bacteria
- Biopsy of the stomach
- Cessation of tobacco smoking
- Stoppage of alcohol
- Stoppage of use of NSAIDs for ulcers caused by taking NSAIDs
- Fluids therapy
- Combination therapy to eradicate H.Pylori bacteria
- Medication to decrease stomach acidity - proton pump inhibitor (PPI) or an H2 blocker
- Follow up, prevention and management of Peptic ulcer complications including Gastrointestinal bleeding, Perforation, peritonitis.Cancer
- Management of anemia due to bleeding complication
- Blood transfusion if ulcers bleeding is severe
- Surgical interventions e.g. endoscopy with open surgery for bleeding ulcers
- Follow up
|
|
60+ years
|
|
|
- Physical and clinical examination
- Diagnostic tests including;
- Endoscopy
- X-rays/barium swallow
- Blood tests for antibodies due to H.pylori
- Urea breath test
- Stool for signs of the bacteria
- Biopsy of the stomach
- Cessation of tobacco smoking
- Stoppage of alcohol
- Stoppage of use of NSAIDs for ulcers caused by taking NSAIDs
- Fluids therapy
- Combination therapy to eradicate H.Pylori bacteria
- Medication to decrease stomach acidity - proton pump inhibitor (PPI) or an H2 blocker
- Follow up, prevention and management of Peptic ulcer complications including Gastrointestinal bleeding; Perforation; peritonitis.Cancer
- Blood transfusion if ulcers bleeding is severe
- Management of anemia due to bleeding complication
- Surgical interventions e.g. endoscopy with open surgery for bleeding ulcers
- Follow up
|
|
Condition: Multiple Sclerosis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
|
|
60+ years
|
|
|
- Physical and clinical examination
- Therapy focused on returning function after an attack, preventing new attacks and preventing disability
- Management of acute attack with high doses of intravenous corticosteroids e.g. oral prednisone and intravenous methylprednisolone
- Diagnostic test
- Paralysis, Depression, Epilepsy
- Blood tests
- Spinal tap (lumbar puncture)
- MRI.
- Plasma exchange (plasmapheresis).
- Follow up and management of complications Including Muscle stiffness or spasms; Paralysis, Depression, Epilepsy
|
|
Condition: Dental Caries
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Investigations including dental x-rays
- Relieve of pain with analgesics
- Use of Local anesthetics, in some cases to relieve pain during or following treatment or to relieve anxiety during treatment.
- Use of topical fluoride to promote remineralization for small lesions
- Dental restorations -Dental fillings for carious lesions using amalgam or composite fillings
- Repair or replacement of fillings where necessary
- Dental extractions
- Endodontic therapy/Root canal treatment
- Use of Crown in extensive caries with little tooth structure left
- Monitor and manage any complication as a result of dental caries such as dental abscesses; gum inflammations
- Follow up
|
|
< 5 years
|
|
|
- Investigations including dental x-rays
- Relieve of pain with analgesics
- Use of Local anesthetics, in some cases to relieve pain during or following treatment or to relieve anxiety during treatment.
- Use of topical fluoride to promote remineralization for small lesions
- Dental restorations -Dental fillings for carious lesions using amalgam or composite fillings
- Repair or replacement of fillings where necessary
- Dental extractions
- Endodontic therapy/Root canal treatment
- Use of Crown in extensive caries with little tooth structure left
- Monitor and manage any complication as a result of dental caries such as dental abscesses, gum inflammations
- Follow up
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
- Investigations including dental x-rays
- Relieve of pain with analgesics
- Use of Local anesthetics, in some cases to relieve pain during or following treatment or to relieve anxiety during treatment.
- Use of topical fluoride to promote remineralization for small lesions
- Dental restorations -Dental fillings for carious lesions using amalgam or composite fillings
- Repair or replacement of fillings where necessary
- Dental extractions
- Endodontic therapy/Root canal treatment
- Use of Crown in extensive caries with little tooth structure left
- Monitor and manage any complication as a result of dental caries such as dental abscesses, gum inflammations
- Follow up
|
|
25 - 59 years
|
|
|
- Investigations including dental x-rays
- Relieve of pain with analgesics
- Use of Local anesthetics, in some cases to relieve pain during or following treatment or to relieve anxiety during treatment.
- Use of topical fluoride to promote remineralization for small lesions
- Dental restorations -Dental fillings for carious lesions using amalgam or composite fillings
- Repair or replacement of fillings where necessary
- Dental extractions
- Endodontic therapy/Root canal treatment
- Use of Crown in extensive caries with little tooth structure left
- Monitor and manage any complication as a result of dental caries such as dental abscesses, gum inflammations
- Follow up
|
|
60+ years
|
|
|
- Investigations including dental x-rays
- Relieve of pain with analgesics
- Use of Local anesthetics, in some cases to relieve pain during or following treatment or to relieve anxiety during treatment.
- Use of topical fluoride to promote remineralization for small lesions
- Dental restorations -Dental fillings for carious lesions using amalgam or composite fillings
- Repair or replacement of fillings where necessary
- Dental extractions
- Endodontic therapy/Root canal treatment
- Use of Crown in extensive caries with little tooth structure left
- Monitor and manage any complication as a result of dental caries such as dental abscesses, gum inflammations
- Follow up
|
|
Condition: Rheumatic Heart Disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Complete physical and clinical examination
- Management of pain with analgesics
- Management of fever with antipyretics
- Use of anti-coagulants with close monitoring including Foetal monitoring
- Antibiotics prophylaxis to avoid recurrence of rheumatic fever and worsening of the rheumatic heart disease.
- Foetal monitoring
- Admissions for close monitoring of women with moderate or severe rheumatic heart disease
- Prevention and management of any maternal cardiac complications in pregnancy due to RHD including heart arrythmias and heart failure, pulmonary oedema
- Prevention and management of delivery complications due to heart damage
- ICU services for women with severe rheumatic heart disease
- Close follow up
- N/B Assessment pre conception or early in pregnancy for women acute rheumatic fever or mild rheumatic disease to establish safest birth pathway
- Diagnostics -tests including.
- Throat swab culture for evidence of streptococcus infection
- Blood tests
- Echocardiogram (echo)- check the heart's chambers and valves
|
|
< 5 years
|
|
|
- Complete Physical and clinical examination
- Diagnostics -tests including;
- Throat swab culture for evidence of streptococcus infection
- Blood tests
- Echocardiogram (echo)-. check the heart's chambers and valves.
- Electrocardiogram (ECG)-.To test the strength and timing of the electrical activity of the heart.
- Chest x-rays
- Cardiac MRI
- Relive pain
- Relive fever
- Management of inflammation with anti-inflammatory medications such as aspirin or corticosteroids
- Antibiotic prophylaxis to prevent recurrent infection with Group A streptococcus. -use/Benzathine penicillin G
- Early identification and treatment of ARF, as well as interventions to prevent recurrences of ARF and therefore reduce the likelihood of RHD.-use of antibiotics,
- Management of heart failure or heart rhythm abnormalities heart failure e.g. with diuretics, beta blockers
- Prevention and management of clotting with blood thinners
- Anti-coagulants
- Surgical interventions including Cardiac catheterization to repair damaged valves or
- ICU services for severely ill patients e.g. post-surgery
- Follow up
|
|
5 - 11 years
|
|
|
- Complete Physical and clinical examination
- Diagnostics -tests including;
- Throat swab culture for evidence of streptococcus infection
- Blood tests
- Echocardiogram (echo)-. check the heart's chambers and valves.
- Electrocardiogram (ECG)-.To test the strength and timing of the electrical activity of the heart.
- Chest x-rays
- Cardiac MRI
- Relive pain
- Relive fever
- Management of inflammation with anti-inflammatory medications such as aspirin or corticosteroids
- Antibiotic prophylaxis to prevent recurrent infection with Group A streptococcus. -use/Benzathine penicillin G
- Early identification and treatment of ARF, as well as interventions to prevent recurrences of ARF and therefore reduce the likelihood of RHD.-use of antibiotics,
- Admissions for management of severe disease/complications
- Management of heart failure or heart rhythm abnormalities heart failure e.g.with diuretics, beta blockers
- Prevention and management of clotting with blood thinners
- Anti-coagulants
- Surgical interventions including Cardiac catheterization to repair damaged valves or
- ICU services for severely ill patients e.g. post-surgery
- Follow up
|
|
12 - 24 years
|
|
|
- Antibiotic therapy
- Analgesics
- Antipyretics
- Heart failure management
- Referral to next level
|
|
25 - 59 years
|
|
|
- Complete Physical and clinical examination
- Diagnostics -tests including;
- Throat swab culture for evidence of streptococcus infection
- Blood tests
- Echocardiogram (echo)-. check the heart's chambers and valves.
- Electrocardiogram (ECG)-.To test the strength and timing of the electrical activity of the heart.
- Chest x-rays
- Cardiac MRI
- Management of pain
- Management of fever
- Management of inflammation with anti-inflammatory medications such as aspirin or corticosteroids
- Antibiotic prophylaxis to prevent recurrent infection with Group A streptococcus. -use/Benzathine penicillin G
- Early identification and treatment of ARF, as well as interventions to prevent recurrences of ARF and therefore reduce the likelihood of RHD.-use of antibiotics,
- Admission to manage severe cases /complications
- Management of heart failure or heart rhythm abnormalities heart failure e.g. with diuretics, beta blockers
- Prevention and management of clotting with blood thinners
- Anti-coagulants
- Surgical interventions including Cardiac catheterization to repair damaged valves
- ICU services for severely ill patients e.g. post-surgery
- Follow up
|
|
60+ years
|
|
|
- Complete Physical and clinical examination
- Diagnostics -tests including;
- Throat swab culture for evidence of streptococcus infection
- Blood tests
- Echocardiogram (echo)-. check the heart's chambers and valves.
- Electrocardiogram (ECG)-.To test the strength and timing of the electrical activity of the heart.
- Chest x-rays
- Cardiac MRI
- Management of pain
- Management of fever
- Management of inflammation with anti-inflammatory medications such as aspirin or corticosteroids
- Antibiotic prophylaxis to prevent recurrent infection with Group A streptococcus. -use/Benzathine penicillin G
- Early identification and treatment of ARF, as well as interventions to prevent recurrences of ARF and therefore reduce the likelihood of RHD.-use of antibiotics,
- Admission to manage severe cases/complications
- Management of heart failure or heart rhythm abnormalities heart failure e.g. with diuretics, beta blockers
- Prevention and management of clotting with blood thinners/anti-coagulants
- Surgical interventions including Cardiac catheterization to repair damaged valves or
- ICU services for severely ill patients e.g. post-surgery
- Follow up
|
|
Condition: Upper Respiratory Tract Infections
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Diagnostic tests including culture and sensitivity, radiological examination (X-rays, CT scans)
- Hydration/fluids therapy
- Management of Nasal congestion/use of decongestants/e.g. pseudoephedrine
- Management of pain -Analgesics e.g. paracetamol and NSAIDs)
- Management of fever
- Management of allergies – use of antihistamines e.g. chlorpheniramine
- Antibiotics therapy e.g. co*amoxiclav
- Management of cough- use of mucolytics
- Vitamin C
- Zinc gluconate
- Humidified hot air
- Follow up, prevention and management of complications such as otitis media, compromised airways
|
|
< 5 years
|
|
|
- Diagnostic tests including culture and sensitivity, radiological examination (X-rays, CT scans)
- Hydration/fluids therapy
- Management of Nasal congestion/use of decongestants/e.g. pseudoephedrine
- Management of pain -Analgesics e.g. paracetamol and NSAIDs)
- Management of fever
- Management of allergies – use of antihistamines e.g. chlorpheniramine
- Antibiotics therapy e.g. co*amoxiclav
- Management of cough- use of mucolytics
- Vitamin C
- Zinc gluconate
- Humidified hot air
- Follow up, prevention and management of complications such as otitis media, compromised airways
|
|
5 - 11 years
|
|
|
- Diagnostic tests including culture and sensitivity, radiological examination (X-rays, CT scans)
- Hydration/fluids therapy
- Management of Nasal congestion/use of decongestants/e.g.pseudoephedrine
- Management of pain -Analgesics e.g. paracetamol and NSAIDs)
- Management of fever
- Management of allergies – use of antihistamines e.g. chlorpheniramine
- Antibiotics therapy e.g. co*amoxiclav
- Management of cough- use of mucolytics
- Vitamin C
- Zinc gluconate
- Humidified hot air
- Follow up, prevention and management of complications such as otitis media, compromised airways
|
|
12 - 24 years
|
|
|
- Diagnostic tests including culture and sensitivity, radiological examination (X-rays, CT scans)
- Hydration/fluids therapy
- Management of Nasal congestion/use of decongestants/e.g. pseudoephedrine
- Management of pain -Analgesics e.g. paracetamol and NSAIDs)
- Management of fever
- Management of allergies – use of antihistamines e.g. chlorpheniramine
- Antibiotics therapy e.g. co*amoxiclav
- Management of cough- use of mucolytics
- Vitamin C
- Zinc gluconate
- Humidified hot air
- Follow up, prevention and management of complications such as otitis media, compromised airways
|
|
25 - 59 years
|
|
|
- Diagnostic tests including culture and sensitivity, radiological examination (X-rays, CT scans)
- Hydration/fluids therapy
- Management of Nasal congestion/use of decongestants/e.g.pseudoephedrine
- Management of pain -Analgesics e.g. paracetamol and NSAIDs)
- Management of fever
- Management of allergies – use of antihistamines e.g. chlorpheniramine
- Antibiotics therapy e.g. co*amoxiclav
- Management of cough- use of mucolytics
- Vitamin C
- Zinc gluconate
- Humidified hot air
- Follow up, prevention and management of complications such as otitis media, compromised airways
|
|
60+ years
|
|
|
- Diagnostic tests including culture and sensitivity, radiological examination (X-rays, CT scans)
- Hydration/fluids therapy
- Management of Nasal congestion/use of decongestants/e.g. pseudoephedrine
- Management of pain -Analgesics e.g. paracetamol and NSAIDs)
- Management of fever
- Management of allergies – use of antihistamines e.g. chlorpheniramine
- Antibiotics therapy e.g. co*amoxiclav
- Management of cough- use of mucolytics
- Vitamin C
- Zinc gluconate
- Humidified hot air
- Follow up, prevention and management of complications such as otitis media, compromised airways
|
|
Condition: Cardiomyopathy - Myocarditis
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Physical and clinical examination
- Diagnostic including;
- Chest X-ray.
- Blood tests
- cardiac CT scans
- Medications e.g for blood pressure;
- Referral to specilised hospitals for specialsied management including of any complications
- Follow up
|
|
60+ years
|
|
|
- Physical and clinical examination
- Diagnostic including;
- Chest X-ray.
- Blood tests
- cardiac CT scans
- Medications e.g for blood pressure;
- Referral to specilised hospitals for specialsied management including of any complications
- Follow up
|
|
Condition: Chronic Obstructive Pulmonary Disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Smoking cessation
- Short-acting beta2-agonists (SABAs)
- Long-acting beta2-agonists (LABA)
- Short-acting antimuscarinic agents (SAMA)
- Long-acting antimuscarinic agents (LAMA)
- Inhaled corticosteroids (ICS)
- Systemic glucocorticoids
- Antibiotics
|
|
60+ years
|
|
|
- Smoking cessation
- Short-acting beta2-agonists (SABAs)
- Long-acting beta2-agonists (LABA)
- Short-acting antimuscarinic agents (SAMA)
- Long-acting antimuscarinic agents (LAMA)
- Inhaled corticosteroids (ICS)
- Systemic glucocorticoids
- Antibiotics
|
|
Condition: Hypertensive heart disease
Community Level
|
Primary Care
|
Referral Facility: General
|
Referral Facility: Specialist
|
Pregnancy and newborn
|
|
|
- Management of gestational hypertension or pre-existing hypertension in pregnant women based on severity and gestational age
- Non-pharmacological management including close supervision, advice on limitation of activities, and some bed rest
- Use of Nutritional supplements eg folic acid
- Review of medication accordingly for mother with pre-existing hypertension
- Blood pressure control in pregnant women
- Admissions for women with moderate to severe gestational or pre-existing hypertension
- Regular testing of proteinuria
- Blood tests-full blood count, renal and liver function test
- Monitoring foetal growth-ultrasound examination
- Follow up
- Post-natal monitoring
|
|
< 5 years
|
|
|
|
|
5 - 11 years
|
|
|
|
|
12 - 24 years
|
|
|
|
|
25 - 59 years
|
|
|
- Tobacco cessation
- Decreased alcohol use
- Increased physical activity
- Low sodium diet
- Thiazide diuretics
- Angiotensin-converting enzyme inhibitors/ angiotensin receptor blockers
- Calcium channel blockers
|
|
60+ years
|
|
|
- Tobacco cessation
- Decreased alcohol use
- Increased physical activity
- Low sodium diet
- Thiazide diuretics
- Angiotensin-converting enzyme inhibitors/ angiotensin receptor blockers
- Calcium channel blockers
|
|